10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2021

or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   For the transition period from                     to                    

Commission File No.: 001-12933

AUTOLIV, INC.

(Exact name of registrant as specified in its charter)

Delaware	51-0378542
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
Klarabergsviadukten 70, Section B7
Box 70381,
Stockholm, Sweden	SE-107 24
(Address of principal executive offices)	(Zip Code)

+46 8 587 20 600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock (par value $1.00 per share)	ALV	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes:  ☒    No:  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes:  ☒    No:  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes:  ☐    No:  ☒

Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date: As of July 12, 2021, there were 87,472,019 shares of common stock of Autoliv, Inc., par value $1.00 per share, outstanding.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. (“Autoliv,” the “Company” or “we”) or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements.

In some cases, you can identify these statements by forward-looking words such as “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “may,” “likely,” “might,” “would,” “should,” “could,” or the negative of these terms and other comparable terminology, although not all forward-looking statements contain such words.

Because these forward-looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward-looking statements for a variety of reasons, including without limitation: general economic conditions; the impacts of the coronavirus (COVID-19) pandemic on the Company’s financial condition, business operations, operating costs, liquidity, competition and the global economy; changes in light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier; supply chain disruptions and component shortages impacting the Company or the automotive industry; changes in general industry and market conditions or regional growth or decline; changes in and the successful execution of our capacity alignment: restructuring and cost reduction and efficiency initiatives and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies, consolidations or restructuring or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing negotiations with customers; successful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; our ability to be awarded new business; product liability, warranty and recall claims and investigations and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims; our ability to protect our intellectual property rights; negative impacts of antitrust investigations or other governmental investigations and associated litigation relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes impacting or limiting our business; political conditions; dependence on and relationships with customers and suppliers; and other risks and uncertainties identified in Item 1A “Risk Factors” of this Quarterly Report on Form 10-Q, Item 1A “Risk Factors” and Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 19, 2021.

For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law.

2

INDEX
PART I - FINANCIAL INFORMATION		4
ITEM 1.  FINANCIAL STATEMENTS		4
1.	Basis of Presentation	9
2.	New Accounting Standards	9
3.	Fair Value Measurements	10
4.	Income Taxes	12
5.	Inventories	12
6.	Restructuring	12
7.	Product-Related Liabilities	13
8.	Retirement Plans	14
9.	Contingent Liabilities	14
10.	Stock Incentive Plan	16
11.	Earnings Per Share	16
12.	Related Party Transactions	16
13.	Revenue Disaggregation	17
14.	Subsequent Events	17
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS		18
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK		30
ITEM 4. CONTROLS AND PROCEDURES		30
PART II - OTHER INFORMATION		31
ITEM 1. LEGAL PROCEEDINGS		31
ITEM 1A. RISK FACTORS		31
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS		31
ITEM 3. DEFAULTS UPON SENIOR SECURITIES		31
ITEM 4. MINE SAFETY DISCLOSURES		31
ITEM 5. OTHER INFORMATION		31
ITEM 6. EXHIBITS		32

3

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

(Dollars in millions, except per share data)

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Net sales	$	2,022		$	1,048		$	4,265		$	2,893
Cost of sales		(1,638	)		(1,033	)		(3,422	)		(2,548	)
Gross profit		384			14			843			345
Selling, general and administrative expenses		(111	)		(98	)		(219	)		(192	)
Research, development and engineering expenses, net		(107	)		(88	)		(213	)		(191	)
Amortization of intangibles		(3	)		(2	)		(5	)		(5	)
Other income (expense), net		0			(59	)		(4	)		(57	)
Operating income (loss)		164			(234	)		401			(99	)
Income from equity method investment		0			0			2			0
Interest income		2			1			2			3
Interest expense		(16	)		(16	)		(32	)		(32	)
Other non-operating items, net		2			1			(4	)		(7	)
Income (loss) before income taxes		152			(247	)		370			(135	)
Income tax (expense) benefit		(48	)		72			(108	)		36
Net income (loss)		105			(174	)		262			(99	)
Less: Net income attributable to non-controlling interest		0			0			1			0
Net income (loss) attributable to controlling interest	$	104		$	(175	)	$	261		$	(100	)
Net earnings (loss) per share – basic 1)	$	1.19		$	(2.00	)	$	2.98		$	(1.14	)
Net earnings (loss) per share – diluted 1)	$	1.19		$	(2.00	)	$	2.98		$	(1.14	)
Weighted average number of shares outstanding, net of    treasury shares (in millions)		87.4			87.3			87.4			87.3
Weighted average number of shares outstanding,    assuming dilution and net of treasury    shares (in millions)		87.7			87.3			87.7			87.3
Cash dividend per share – declared 2), 3)	$	0.62		$	—		$	0.62		$	—
Cash dividend per share – paid 3)	$	0.62		$	—		$	0.62		$	0.62

1) Participating share awards with the right to receive dividend equivalents are (under the two-class method) excluded from the earnings per share calculation (see Note 11 to the unaudited condensed consolidated financial statements).

2) As earlier communicated, on April 2, 2020, the Company announced it canceled its declared dividend for the second quarter of 2020.

3) On May 12, 2021, the Company announced it will reinstate quarterly dividends and declared a dividend of 62 cents for the second quarter of 2021.

See Notes to the unaudited Condensed Consolidated Financial Statements.

4

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(Dollars in millions)

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Net income (loss)	$	105		$	(174	)	$	262		$	(99	)
Other comprehensive income (loss) before tax:
Change in cumulative translation adjustments		37			27			(27	)		(75	)
Net change in unrealized components of defined benefit plans		1			3			3			4
Other comprehensive income (loss), before tax		38			30			(24	)		(71	)
Tax effect allocated to other comprehensive loss		(0	)		(1	)		(1	)		(1	)
Other comprehensive income (loss), net of tax		38			29			(25	)		(72	)
Comprehensive income (loss)		143			(145	)		237			(172	)
Less: Comprehensive income attributable to    non-controlling interest		1			1			1			0
Comprehensive income (loss) attributable to    controlling interest	$	142		$	(146	)	$	236		$	(172	)

See Notes to the unaudited Condensed Consolidated Financial Statements.

5

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Dollars in millions)

	As of
	June 30, 2021			December 31, 2020
Assets
Cash and cash equivalents	$	893		$	1,178
Receivables, net		1,719			1,822
Inventories, net		901			798
Prepaid expenses and accrued income		230			164
Other current assets		60			307
Total current assets		3,804			4,269
Property, plant and equipment, net		1,833			1,869
Operating lease right-of-use assets		133			141
Goodwill		1,393			1,398
Intangible assets, net		11			14
Other non-current assets		462			466
Total assets	$	7,636		$	8,157
Liabilities and equity
Short-term debt	$	363		$	302
Accounts payable		1,125			1,254
Accrued expenses		1,066			1,270
Operating lease liabilities - current		39			37
Other current liabilities		260			284
Total current liabilities		2,852			3,147
Long-term debt		1,712			2,110
Pension liability		239			248
Operating lease liabilities - non-current		94			103
Other non-current liabilities		125			126
Total non-current liabilities		2,170			2,587
Common stock		103			103
Additional paid-in capital		1,329			1,329
Retained earnings		2,678			2,471
Accumulated other comprehensive loss		(372	)		(347	)
Treasury stock		(1,138	)		(1,147	)
Total controlling interest's equity		2,600			2,409
Non-controlling interest		15			14
Total equity		2,615			2,423
Total liabilities and equity	$	7,636		$	8,157

See Notes to the unaudited condensed consolidated financial statements.

6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Dollars in millions)

	Six months ended June 30
	2021			2020
Operating activities
Net income (loss)	$	262		$	(99	)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization		199			175
Deferred income taxes		3			(101	)
Other, net		(1	)		28
Net change in operating assets and liabilities		(214	)		25
Net cash provided by operating activities		249			28
Investing activities
Expenditures for property, plant and equipment		(191	)		(154	)
Proceeds from sale of property, plant and equipment		1			2
Net cash used in investing activities		(189	)		(152	)
Financing activities
Net decrease in short-term debt		(291	)		(142	)
Increase in long-term debt		14			1,720
Decrease in long-term debt		—			(630	)
Dividends paid		(54	)		(54	)
Common stock options exercised		2			0
Net cash (used in) provided by financing activities		(329	)		895
Effect of exchange rate changes on cash and cash equivalents		(16	)		8
(Decrease) increase in cash and cash equivalents		(285	)		779
Cash and cash equivalents at beginning of period		1,178			445
Cash and cash equivalents at end of period	$	893		$	1,223

See Notes to unaudited condensed consolidated financial statements.

7

CONSOLIDATED STATEMENTS OF TOTAL EQUITY (UNAUDITED)

(Dollars in millions)

	Common stock		Additional paid-in capital		Retained earnings			Accumulated other comprehensive loss			Treasury stock			Total controlling interest's equity			Non- controlling interest		Total equity
Balances at December 31, 2020	$	103	$	1,329	$	2,471		$	(347	)	$	(1,147	)	$	2,409		$	14	$	2,423
Comprehensive Income:
Net income						157									157			0		157
Foreign currency translation    adjustment									(64	)					(64	)		0		(64	)
Pension liability									1						1			—		1
Total Comprehensive Income		—		—		157			(63	)		—			94			0		94
Stock-based compensation												4			4					4
Balances at March 31, 2021		103		1,329		2,628			(410	)		(1,143	)		2,507			14		2,521
Comprehensive Income:
Net income						104									104			1		105
Foreign currency translation    adjustment									37						37			0		37
Pension liability									1						1			—		1
Total Comprehensive Income		—		—		104			38			—			142			1		143
Stock-based compensation												5			5			—		5
Cash dividends declared1)						(54	)								(54	)				(54	)
Balances at June 30, 2021	$	103	$	1,329	$	2,678		$	(372	)	$	(1,138	)	$	2,600		$	15	$	2,615

1) Dividend for the second quarter of 2021 was declared on May 12, 2021.

	Common stock		Additional paid-in capital		Retained earnings			Accumulated other comprehensive loss			Treasury stock			Total controlling interest's equity			Non- controlling interest			Total equity
Balances at December 31, 2019	$	103	$	1,329	$	2,284		$	(449	)	$	(1,158	)	$	2,109		$	13		$	2,122
Comprehensive Loss:
Net income						75									75			0			75
Foreign currency translation    adjustment									(102	)					(102	)		(0	)		(102	)
Pension liability									1						1						1
Total Comprehensive Loss		—		—		75			(101	)		—			(26	)		(0	)		(26	)
Stock-based compensation												2			2						2
Cash dividends declared 1)						(54	)								(54	)					(54	)
Balances at March 31, 2020		103		1,329		2,305			(550	)		(1,156	)		2,031			13			2,044
Comprehensive Loss:
Net (loss) income						(175	)								(175	)		1			(174	)
Foreign currency translation    adjustment									27						27			(0	)		27
Pension liability									2						2						2
Total Comprehensive Loss		—		—		(175	)		29			—			(146	)		1			(145	)
Stock-based compensation									0			2			2						2
Cash dividends declared1)						54									54						54
Balances at June 30, 2020	$	103	$	1,329	$	2,184		$	(521	)	$	(1,154	)	$	1,942		$	14		$	1,955

1) Reversal of canceled dividend declared for the second quarter of 2020 which was announced by the Company on April 2, 2020.

See Notes to the unaudited Condensed Consolidated Financial Statements.

8

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unless otherwise noted, all amounts are presented in millions of dollars, except for per share amounts)

June 30, 2021

1. BASIS OF PRESENTATION

The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the prior year audited consolidated financial statements and all adjustments considered necessary for a fair presentation have been included in the consolidated financial statements. All such adjustments are of a normal recurring nature. The results for the interim period are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending December 31, 2021.

The Condensed Consolidated Balance Sheet at December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements.

The Company has one reportable segment, which includes Autoliv’s airbag and seatbelt products and components.

Certain amounts in the condensed consolidated financial statements and associated notes may not reconcile due to rounding. All percentages have been calculated using unrounded amounts. Certain amounts in prior periods have been reclassified to conform to current year presentation.

Statements in this report that are not of historical fact are forward-looking statements that involve risks and uncertainties that could affect the actual results of the Company. A description of the important factors that could cause Autoliv’s actual results to differ materially from the forward-looking statements contained in this report may be found in this report and Autoliv’s other reports filed with the Securities and Exchange Commission (the "SEC"). For further information, refer to the consolidated financial statements, footnotes and definitions thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 19, 2021.

2. NEW ACCOUNTING STANDARDS

Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates ("ASUs") to the FASB’s Accounting Standards Codification ("ASC").

The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s consolidated financial statements.

Adoption of new accounting standards

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes. ASU 2019-12 is effective for public business entities for annual periods beginning after December 15, 2020, and early adoption is permitted. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The Company adopted ASU 2019-12 prospectively as of January 1, 2021, and the adoption did not have a material impact on the Company’s consolidated financial statements.

Accounting standards issued but not yet adopted

None that are expected to have an impact on the Company. 

9

3. FAIR VALUE MEASUREMENTS

Assets and liabilities measured at fair value on a recurring basis

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and other current financial assets and liabilities approximate their fair value because of the short-term maturity of these instruments.

The Company uses derivative financial instruments (“derivatives”) as part of its debt management to mitigate the market risk that occurs from its exposure to changes in interest rates and foreign exchange rates. The Company does not enter into derivatives for trading or other speculative purposes. The Company’s use of derivatives is in accordance with the strategies contained in the Company’s overall financial policy. All derivatives are recognized in the consolidated financial statements at fair value. For certain derivatives, hedge accounting is not applied either because non-hedge accounting treatment creates the same accounting result or the hedge does not meet the hedge accounting requirements, although each hedge is entered into applying the same rationale concerning mitigating market risk that occurs from changes in interest rates and foreign exchange rates.

The degree of judgment utilized in measuring the fair value of the instruments generally correlates to the level of pricing observability. Pricing observability is impacted by several factors, including the type of asset or liability, whether the asset or liability has an established market and the characteristics specific to the transaction. Instruments with readily active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of pricing observability and a lesser degree of judgment utilized in measuring fair value. Conversely, assets rarely traded or not quoted will generally have less, or no, pricing observability and a higher degree of judgment utilized in measuring fair value.

All the Company’s derivatives are classified as Level 2 financial instruments in the fair value hierarchy. Level 2 pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reported date. The nature of these assets and liabilities include items for which quoted prices are available but traded less frequently, and items that are fair valued using other financial instruments, the parameters of which can be directly observed.

The carrying value is the same as the fair value as these instruments are recognized in the consolidated financial statements at fair value. Although the Company is party to close-out netting agreements ("ISDA agreements") with all derivative counterparties, the fair values in the tables below and in the Condensed Consolidated Balance Sheets at June 30, 2021 and December 31, 2020 have been presented on a gross basis. According to the ISDA agreements, transaction amounts payable to a counterparty on the same date and in the same currency can be netted. The amounts subject to netting agreements that the Company chose not to offset are presented below.

Derivatives designated as hedging instruments

There were no derivatives designated as hedging instruments as of June 30, 2021 and December 31, 2020 related to the operations.

Derivatives not designated as hedging instruments

Derivatives not designated as hedging instruments relate to economic hedges and are marked to market with all amounts recognized in the Consolidated Statements of Income. The derivatives not designated as hedging instruments outstanding at June 30, 2021 and December 31, 2020 were foreign exchange swaps.

For the three month periods ended June 30, 2021 and June 30, 2020, the gains and losses recognized in other non-operating items, net were a gain of $20 million and a gain of $7 million, respectively, for derivative instruments not designated as hedging instruments. For the six month periods ended June 30, 2021 and June 30, 2020, the gains and losses recognized in other non-operating items, net were a loss of $38 million and a loss of $2 million, respectively, for derivative instruments not designated as hedging instruments. The realized part of the gains and losses referred to above are reported under financing activities in the statement of cash flows.

10

For the three and six month periods ended June 30, 2021 and June 30, 2020, the gains and losses recognized as interest expense were immaterial.

The tables below present information about the Company’s derivative financial assets and liabilities measured at fair value on a recurring basis (dollars in millions).

	June 30, 2021									December 31, 2020
				Fair Value Measurements									Fair Value Measurements
Description	Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)			Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)
Derivatives not designated as hedging    instruments
Foreign exchange swaps, less    than 6 months	$	1,300	1)	$	1	2)	$	16	3)	$	1,463	4)	$	25	5)	$	3	6)
Total derivatives not designated    as hedging instruments	$	1,300		$	1		$	16		$	1,463		$	25		$	3

1) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,300 million.

2) Net amount after deducting for offsetting swaps under ISDA agreements is $1 million.

3) Net amount after deducting for offsetting swaps under ISDA agreements is $16 million.

4) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,463 million.

5) Net amount after deducting for offsetting swaps under ISDA agreements is $25 million.

6) Net amount after deducting for offsetting swaps under ISDA agreements is $3 million.

Fair Value of Debt

The fair value of long-term debt is determined either from quoted market prices as provided by participants in the secondary market or for long-term debt without quoted market prices, estimated using a discounted cash flow method based on the Company’s current borrowing rates for similar types of financing. The Company has determined that each of these fair value measurements of debt reside within Level 2 of the fair value hierarchy.

The fair value and carrying value of debt is summarized in the table below (dollars in millions).

	June 30, 2021				December 31, 2020
	Carrying value1)		Fair value		Carrying value1)		Fair value
Long-term debt
Bonds	$	1,359	$	1,453	$	1,377	$	1,483
Loans		352		367		732		753
Other long-term debt		1		1		1		1
Total long-term debt		1,712		1,821		2,110		2,237
Short-term debt
Short-term portion of long-term debt		353		356		275		278
Overdrafts and other short-term debt		10		10		27		27
Total short-term debt	$	363	$	366	$	302	$	305

1) Debt as reported in balance sheet.

Assets and liabilities measured at fair value on a nonrecurring basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company also has assets and liabilities in its balance sheet that are measured at fair value on a nonrecurring basis, including certain long-lived assets, including equity method investments, goodwill and other intangible assets, typically as it relates to impairment.

11

The Company has determined that the fair value measurements included in each of these assets and liabilities rely primarily on Company-specific inputs and the Company’s assumptions about the use of the assets and settlements of liabilities, as observable inputs are not available. The Company has determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. To determine the fair value of long-lived assets, the Company utilizes the projected cash flows expected to be generated by the long-lived assets, then discounts the future cash flows over the expected life of the long-lived assets.

For the three and six month periods ended June 30, 2021 and June 30, 2020, the Company did not record any material impairment charges on its long-lived assets for its operations.

4. INCOME TAXES

The effective tax rate for the three months period ended June 30, 2021 was 31.3% compared to 29.3% for the three months period ended June 30, 2020. Discrete tax items, net for the three months period ended June 30, 2021 had an unfavorable impact of 0.2%. Discrete tax items, net for the three months period ended June 30, 2020 had a favorable impact of 4.4%.

The effective tax rate for the six months period ended June 30, 2021 was 29.2% compared to 26.5% for the six months period ended June 30, 2020. Discrete tax items, net for the six months period ended June 30, 2021 had a favorable impact of 0.1%. Discrete tax items, net for the six months period ended June 30, 2020, had a favorable impact of 7.6%.

The Company files income tax returns in the U.S. federal jurisdiction, various U.S. states and non-U.S. jurisdictions. At any given time, the Company is undergoing tax audits in several tax jurisdictions covering multiple years. The Company is no longer subject to income tax examination by the U.S. federal income tax authorities for years prior to 2015. With few exceptions, the Company is no longer subject to income tax examination by U.S. state or local tax authorities or by non-U.S. tax authorities for years before 2010.

As of June 30, 2021, the Company is not aware of any proposed income tax adjustments resulting from tax examinations that would have a material impact on the Company’s condensed consolidated financial statements. The conclusion of such audits could result in additional increases or decreases to unrecognized tax benefits in some future period or periods.

During the six months period ended June 30, 2021, the Company recorded a net increase of $4 million to income tax reserves for unrecognized tax benefits based on tax positions related to the current year, including accruing additional interest related to unrecognized tax benefits from prior years. Of the total unrecognized tax benefits of $50 million recorded at June 30, 2021, $6 million is classified as current tax payable within Other current liabilities and $44 million is classified as non-current tax payable within Other non-current liabilities on the Condensed Consolidated Balance Sheet.

5. INVENTORIES

Inventories are stated at the lower of cost ("FIFO") and net realizable value. The components of inventories were as follows (dollars in millions):

	As of
	June 30, 2021			December 31, 2020
Raw materials	$	416		$	379
Work in progress		326			292
Finished products		249			220
Inventories		991			891
Inventory valuation reserve		(90	)		(93	)
Total inventories, net of reserve	$	901		$	798

6. RESTRUCTURING

As of June 30, 2021, approximately $52 million out of the $107 million in total reserve balance can be attributed to the structural efficiency program initiated in the second quarter of 2020. This program is expected to be concluded in 2021. Approximately $38 million of the total reserve balance can be attributed to footprint optimization activities in Europe initiated in the third quarter of 2020. These activities are expected to be concluded in 2023.

12

The table below summarizes the change in the balance sheet position of the employee related restructuring reserves (dollars in millions). The restructuring reserve balance is included within Accrued expenses in the Condensed Consolidated Balance Sheet. The changes in the employee-related reserves have been charged against Other income (expense), net in the Consolidated Statements of Income. Restructuring costs other than employee related costs are immaterial for all periods presented.

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Reserve at beginning of the period	$	113		$	52		$	126		$	56
Provision - charge		1			69			2			71
Provision - reversal		(0	)		(7	)		(0	)		(7	)
Cash payments		(8	)		(16	)		(17	)		(20	)
Translation difference		1			2			(4	)		0
Reserve at end of the period	$	107		$	100		$	107		$	100

7. PRODUCT-RELATED LIABILITIES

The Company is exposed to product liability and warranty claims in the event that the Company’s products fail to perform as represented and such failure results, or is alleged to result, in bodily injury, and/or property damage or other loss. The Company has reserves for product risks. Such reserves are related to product performance issues, including recalls, product liability and warranty issues. For further explanation, see Note 9. Contingent Liabilities below.

For the three and six month periods ended June 30, 2021, provisions primarily related to recall related issues. Cash payments in the three and six month periods ended June 30, 2021 mainly related to the “Toyota Recall” that was settled in April 2021. For the three and six month periods ended June 30, 2020, provisions and cash paid primarily related to recall and warranty related issues. As of June 30, 2021, the reserve for product related liabilities mainly related to recall related issues.

Pursuant to the agreements entered into in connection with the spin-off of Veoneer, Inc. on June 29, 2018 (collectively, the “Spin-off Agreements”), Autoliv is required to indemnify Veoneer for recalls related to certain qualified Electronics products. As of June 30, 2021, the indemnification liabilities are approximately $8 million and included within Accrued expenses on the Condensed Consolidated Balance Sheet.

The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions). A majority of the Company’s recall related issues as of June 30, 2021 are covered by insurance. Insurance receivables are included within Other current assets and Other non-current assets on the Condensed Consolidated Balance Sheet. As of June 30, 2021, the Company had total insurance receivables related to recall issues of $126 million. The total product liability reserve currently is less than the product liability insurance receivable because the timing of insurance recoveries does not match the timing of our product liability.

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Reserve at beginning of the period	$	328		$	54		$	341		$	72
Change in reserve		1			8			5			11
Cash payments		(237	)		(4	)		(243	)		(25	)
Translation difference		11			0			0			0
Reserve at end of the period	$	103		$	58		$	103		$	58

13

8. RETIREMENT PLANS

The components of total Net Periodic Benefit Cost associated with the Company’s defined benefit retirement plans are as follows (dollars in millions):

U.S. Plans	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Service cost	$	2		$	2		$	4		$	4
Interest cost		2			3			5			7
Expected return on plan assets		(5	)		(4	)		(9	)		(8	)
Amortization of prior service (credit) cost		1			(1	)		0			(1	)
Amortization of actuarial loss		1			1			1			1
Net Periodic Benefit Cost	$	1		$	1		$	1		$	3
Non-U.S. Plans	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Service cost	$	3		$	3		$	6		$	6
Interest cost		2			1			3			3
Expected return on plan assets		(1	)		(0	)		(1	)		(1	)
Amortization of prior service (credit) cost		(0	)		0			0			0
Amortization of actuarial loss		1			0			1			1
Net Periodic Benefit Cost	$	5		$	4		$	9		$	9

The Service cost and Amortization of prior service cost components in the tables above are reported in Operating Income in the Consolidated Statements of Income. The remaining components - Interest cost, Expected return on plan assets, Amortization of actuarial loss and Settlement loss - are reported as Other non-operating items, net in the Consolidated Statements of Income.

9. CONTINGENT LIABILITIES

Legal Proceedings

Various claims, lawsuits and proceedings are pending or threatened against the Company or its subsidiaries, covering a range of matters that arise in the ordinary course of its business activities with respect to commercial, product liability and other matters. Litigation is subject to many uncertainties, and the outcome of any litigation cannot be assured. After discussions with counsel, it is the opinion of management that the various legal proceedings and investigations to which the Company currently is a party will not have a material adverse impact on the consolidated financial position of Autoliv, but the Company cannot provide assurance that Autoliv will not experience material litigation, product liability or other losses in the future.

ANTITRUST MATTERS

Authorities in several jurisdictions have conducted broad, and in some cases, long-running investigations of suspected anti-competitive behavior among parts suppliers in the global automotive vehicle industry. These investigations included, but are not limited to, the products that the Company sells. In addition to concluded matters, authorities of other countries with significant light vehicle manufacturing or sales may initiate similar investigations.

PRODUCT WARRANTY, RECALLS AND INTELLECTUAL PROPERTY

Autoliv is exposed to various claims for damages and compensation if its products fail to perform as expected. Such claims can be made, and result in costs and other losses to the Company, even where the product is eventually found to have functioned properly. Where a product (actually or allegedly) fails to perform as expected or is defective, the Company may face warranty and recall claims. Where such (actual or alleged) failure or defect results, or is alleged to result, in bodily injury and/or property damage or other loss, the Company may also face product liability and other claims. There can be no assurance that the Company will not experience material warranty, recall or product (or other) liability claims or losses in the future, or that the Company will not incur significant costs to defend against such claims. The Company may be required to participate in a recall involving its products. Each vehicle manufacturer has its own practices regarding product recalls and other product liability actions relating to its suppliers. As suppliers become more integrally involved in the vehicle design process and assume more of the vehicle assembly functions, vehicle manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and product liability claims. Government safety regulators may also play a role in warranty and recall practices. A warranty, recall or product-liability claim

14

brought against the Company in excess of its insurance may have a material adverse effect on the Company’s business. Vehicle manufacturers are also increasingly requiring their outside suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties. A vehicle manufacturer may attempt to hold the Company responsible for some, or all, of the repair or replacement costs of products when the product supplied did not perform as represented by us or expected by the customer. Accordingly, the future costs of warranty claims by customers may be material. However, the Company believes its established reserves are adequate. Autoliv’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.

In addition, as vehicle manufacturers increasingly use global platforms and procedures, quality performance evaluations are also conducted on a global basis. Any one or more quality, warranty or other recall issue(s) (including those affecting few units and/or having a small financial impact) may cause a vehicle manufacturer to implement measures such as a temporary or prolonged suspension of new orders, which may have a material impact on the Company’s results of operations.

The Company maintains a program of insurance, which may include commercial insurance, self-insurance, or a combination of both approaches, for potential recall and product liability claims in amounts and on terms that it believes are reasonable and prudent based on our prior claims experience. The Company’s insurance policies generally include coverage of the costs of a recall, although costs related to replacement parts are generally not covered. In addition, a number of the agreements entered into by the Company, including the Spin-off Agreements, require Autoliv to indemnify the other parties for certain claims. Autoliv cannot assure that the level of coverage will be sufficient to cover every possible claim that can arise in our businesses or with respect to other obligations, now or in the future, or that such coverage always will be available should we, now or in the future, wish to extend, increase or otherwise adjust our insurance.

Specific Recalls:

On June 29, 2016, the Company announced that it was cooperating with Toyota Motor Corp. in its recall of approximately 1.4 million vehicles equipped with a certain model of the Company’s side curtain airbag (the “Toyota Recall”). The Company determined pursuant to ASC 450 that a loss with respect to the Toyota Recall was probable and accrued an amount that was included in the total product liability accrual in the fourth quarter of 2020. The amount by which the product liability accrual exceeded the product liability insurance receivable with respect to the Toyota Recall was $25 million and included deductibles and replacement parts. The Company settled and resolved the Toyota Recall on April 27, 2021. The final amount by which the product liability accrual exceeded the product liability insurance receivable was $26 million, which is generally in line with our expectations disclosed in prior quarters. The matter is now closed.

Additionally, in the fourth quarter of 2020, the Company was made aware of a potential recall by one of its customers (the “Unannounced Recall”). The Company continues to evaluate this matter with its customer. The Company has determined pursuant to ASC 450 that a loss with respect to the Unannounced Recall is probable and has accrued an amount that is reflected in the total product liability accrual in the fourth quarter of 2020. The amount by which the product liability accrual exceeds the product liability insurance receivable with respect to the Unannounced Recall is $26 million and includes self-insurance retention costs and deductibles. The ultimate loss to the Company of the Unannounced Recall could be materially different from the amount the Company has accrued.

Intellectual Property:

In its products, the Company utilizes technologies which may be subject to intellectual property rights of third parties. While the Company does seek to procure the necessary rights to utilize intellectual property rights associated with its products, it may fail to do so. Where the Company so fails, the Company may be exposed to material claims from the owners of such rights. Where the Company has sold products which infringe upon such rights, its customers may be entitled to be indemnified by the Company for the claims they suffer as a result thereof. Such claims could be material.

The table in Note 7. Product-Related Liabilities above summarizes the change in the balance sheet position of the product-related liabilities.

15

10. STOCK INCENTIVE PLAN

Eligible employees and non-employee directors of the Company participate in the Autoliv, Inc.1997 Stock Incentive Plan, as amended and received Autoliv stock-based awards which include stock options ("SOs"), restricted stock units ("RSUs") and performance stock units ("PSUs").

For the three and six month periods ended June 30, 2021, the Company recorded approximately $4 million and $7 million, respectively, in stock-based compensation expense related to RSUs and PSUs. For the three and six month periods ended June 30, 2020, the Company recorded approximately $2 million and $4 million, respectively, in stock-based compensation expense related to RSUs and PSUs.

During the three and six month periods ended June 30, 2021, approximately 47 thousand and 116 thousand shares, respectively, of common stock from the treasury stock were utilized by the Plan. During the three and six month periods ended June 30, 2020, approximately 16 thousand and 86 thousand shares, respectively, of common stock from the treasury stock were utilized by the Plan.

11. EARNINGS PER SHARE

The computation of basic and diluted EPS under the two-class method is set forth in the table below. Anti-dilutive shares outstanding were immaterial for all periods presented below. For the three and six month periods ended June 30, 2020, shares in the diluted loss per share calculation represent basic shares due to the net loss.

	Three months ended June 30					Six months ended June 30
(In millions, except per share amounts)	2021		2020			2021		2020
Numerator:
Basic and diluted:
Net income (loss) attributable to controlling interest	$	104	$	(175	)	$	261	$	(100	)
Participating share awards with dividend    equivalent rights		0		0			0		0
Net income (loss) applicable to common    shareholders		104		(175	)		261		(100	)
Earnings allocated to participating    share awards1)		0		0			0		0
Net income (loss) attributable to common    shareholders	$	104	$	(175	)	$	261	$	(100	)
Denominator: 1)
Basic: Weighted average common stock		87.4		87.3			87.4		87.3
Add: Weighted average stock options/    share awards		0.3		0.0			0.3		0.0
Diluted:		87.7		87.3			87.7		87.3
Net earnings (loss) per share - basic	$	1.19	$	(2.00	)	$	2.98	$	(1.14	)
Net earnings (loss) per share - diluted	$	1.19	$	(2.00	)	$	2.98	$	(1.14	)

1) The Company’s unvested RSUs and PSUs, of which some included the right to receive non-forfeitable dividend equivalents, are considered participating securities. Calculations of EPS under the two-class method exclude from the numerator any dividends paid or owed on participating securities and any undistributed earnings considered to be attributable to participating securities. The related participating securities are similarly excluded from the denominator.

12. RELATED PARTY TRANSACTIONS

The Company purchases finished goods from Veoneer. For the three and six month periods ended June 30, 2021, related party purchases from Veoneer amounted to $20 million and $41 million, respectively. For the three and six month periods ended June 30, 2020, related party purchases from Veoneer amounted to $11 million and $29 million, respectively.

Amounts due to and due from related party as of June 30, 2021 and December 31, 2020 were as follows:

	As of
(Dollars in millions)	June 30, 2021		December 31, 2020
Related party receivables1)	$	1	$	2
Related party payables2)		26		27
Related party accrued expenses3)		8		10

1) Included in Receivables, net in the Condensed Consolidated Balance Sheet.

16

2) Included in Accounts payable in the Condensed Consolidated Balance Sheet.

3) Included in Accrued expenses in the Condensed Consolidated Balance Sheet.

13. REVENUE DISAGGREGATION

The Company’s disaggregated revenue for the three and six month periods ended June 30, 2021 and June 30, 2020 were as follows.

Net Sales by Products	Three months ended June 30				Six months ended June 30
(Dollars in millions)	2021		2020		2021		2020
Airbag Products and Other1)	$	1,310	$	654	$	2,773	$	1,856
Seatbelt Products1)		712		394		1,491		1,037
Total net sales	$	2,022	$	1,048	$	4,265	$	2,893
1) Including Corporate and other sales.
Net Sales by Region	Three months ended June 30				Six months ended June 30
(Dollars in millions)	2021		2020		2021		2020
Asia	$	794	$	588	$	1,671	$	1,185
Whereof: China		399		366		814		564
Japan		175		105		386		308
Rest of Asia		219		117		471		314
Americas		621		213		1,307		886
Europe		608		246		1,287		823
Total net sales	$	2,022	$	1,048	$	4,265	$	2,893

Contract Balances

Contract assets relate to the Company's rights to consideration for work completed but not billed (generally in conjunction with contracts for which revenue is recognized over time) at the reporting date on production parts and is included in Other current assets in the Condensed Consolidated Balance Sheet. The contract assets are reclassified into the receivables balance when the rights to receive payments become unconditional. The net change in the contract assets balance, reflecting the adjustments needed to align revenue recognition for work completed but not billed, for the three and six month periods ended June 30, 2021 and for the three and six month periods ended June 30, 2020 were not material in any period.

14. SUBSEQUENT EVENTS

There were no reportable events subsequent to June 30, 2021.

17

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our Condensed Consolidated Financial Statements and accompanying Notes thereto included elsewhere herein and with our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the United States Securities and Exchange Commission (the “SEC”) on February 19, 2021. Unless otherwise noted, all dollar amounts are in millions.

Autoliv, Inc. (“Autoliv” or the “Company”) is a Delaware corporation with its principal executive offices in Stockholm, Sweden. The Company functions as a holding corporation and owns two principal operating subsidiaries, Autoliv AB and Autoliv ASP, Inc.

Through its operating subsidiaries, Autoliv is a supplier of automotive safety systems with a broad range of product offerings, including modules and components for passenger and driver airbags, side airbags, curtain airbags, seatbelts, steering wheels and pedestrian protection systems.

Autoliv’s filings with the SEC, including this Quarterly Report on Form 10-Q, annual reports on Form 10-K, current reports on Form 8-K, proxy statements and all of our other reports and statements, and amendments thereto, are available free of charge on our corporate website at www.autoliv.com as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC (generally the same day as the filing).

The primary exchange market for Autoliv’s securities is the New York Stock Exchange ("NYSE") where Autoliv’s common stock trades under the symbol “ALV”. Autoliv’s Swedish Depositary Receipts ("SDRs") are traded on Nasdaq Stockholm’s list for large market cap companies under the symbol “ALIV SDB”. Options in SDRs trade on Nasdaq Stockholm under the name “Autoliv SDB”.  Options in Autoliv shares are traded on Nasdaq OMX PHLX and on NYSE Amex Options under the symbol “ALV”.

Autoliv’s fiscal year ends on December 31.

EXECUTIVE OVERVIEW

The COVID-19 pandemic continues to affect the Company in several ways. Supply shortage of semiconductors resulted in a Q2 global LVP that was 8% lower than what was expected at the beginning of the quarter, and 8% lower than the first quarter (according to IHS Markit June 2021). The lower than anticipated LVP, along with the material changes in customer call-offs with short notice, negatively impacted the Company's sales and profitability in the quarter. The low visibility of these changes prevented the Company from using furloughs effectively to mitigate the effects of the lower customer demand. Although the situation improved towards the end of the quarter, the Company still expects supply disruptions to impact LVP negatively in the third quarter with some improvement in the fourth quarter.

The Company is satisfied with its strong sales growth and outperformance versus LVP in the second quarter, and the level of the Company's order intake for the first half of the year. The Company is also satisfied with its leverage ratio (Non-U.S. GAAP measure) coming down to 1.1x. The Company also reinstated a quarterly dividend during the second quarter.

The Company took an important sustainability step in the quarter when it announced ambitious climate targets. This includes plans to become carbon neutral in the Company's own operations by 2030, aiming for net-zero emissions across its supply chain by 2040, and committing to the Science Based Targets initiative.

Raw material prices have continued to increase, with some key commodities increasing by more than 20% in the past three months, and despite significant mitigation actions, the Company now expects raw material cost for the full year to amount to around 130 basis points operating margin headwind.

The Company continues to be diligent in its cost control to manage demand volatility. However, as a result of continued demand and supply chain uncertainty, the Company is adjusting its full year indications. Based on an assumption of 9-11% global LVP growth for the full year 2021, the Company expects an organic sales growth of around 16-18%, and an adjusted operating margin of around 9-9.5%.

The Company also continues to drive forward with its strategic initiatives, such as increased digitalization and automation of the value chain, which are yielding good results. The Company's internal progress and a light vehicle market outlook with a production recovery in the next few years makes management confident of the Company's 2022-24 targets of average annual 4-5% growth over LVP and 12% adjusted operating margin. The Company will elaborate on this and its long-term opportunities at the Company's virtual CMD on November 16, 2021.

18

Financial highlights in the second quarter of 2021

$2,022 million net sales

85% organic sales growth (Non-U.S. GAAP measure, see reconciliation table below)

8.1% operating margin

8.2% adjusted operating margin (Non-U.S. GAAP measure, see reconciliation table below)

$1.19 EPS - an increase of $3.19

$1.20 adjusted EPS (Non-U.S. GAAP measure, see reconciliation table below) - an increase of $2.60

Key business developments in the second quarter of 2021

Strong organic sales growth (Non-U.S. GAAP measure) in all regions, except China, as global LVP grew by 52% vs. Q2 last year (according to IHS Markit June 2021). Sales increased organically (Non-U.S. GAAP measure, see reconciliation table below) by 85%, outperforming global LVP by more than 33pp, largely due to launches and positive vehicle and geographical mix effects. All regions except Rest of Asia outperformed LVP by 4-38pp. Sequentially, LVP declined by 8% compared to Q1 2021.

Major profitability improvement, mainly driven by the strong sales growth. Adjusted operating margin (Non-U.S. GAAP measure, see reconciliation table below) improved by 24.6 pp to 8.2%. ROCE improved to 17.7% and ROE improved to 16.3%.

Improved cash flow and balance sheet. Operating cash flow increased to $63 million while operating cash flow less capital expenditures, net was negative $33 million. Net debt (Non-U.S. GAAP measure, see reconciliation table below) declined substantially and our leverage ratio (Non-U.S. GAAP measure, see calculation below) improved to 1.1x. Quarterly dividend of $0.62 was declared for Q2 2021.

COVID-19 pandemic related business update

The COVID-19 pandemic continued to impact the Company's business in the second quarter 2021 both directly through several weeks long lock-downs in India and indirectly through limited LVP by its customers caused by semiconductor and other industry supply chain disruptions, especially in North America and Europe. Second quarter 2021 global LVP was around 8% lower than expected at the beginning of the quarter (according to IHS Markit June 20211)). Although the Company has fulfilled its delivery commitments, the lower than anticipated LVP has negatively impacted the Company's sales and profitability. Supply chain disruptions leading to low customer demand visibility and material changes to call-offs with short notice also negatively impacted the Company's production efficiency and profitability in the quarter.

Direct COVID-19 related costs, such as personal protective equipment, quarantine costs, premium freight and other items were around $3 million in Q2 2021. Governmental support in connection with furloughing, short-term work weeks, and other similar activities was not material to the Company's financial results in Q2 2021.

The current industry-wide semiconductor shortage will continue to negatively impact LVP, and hence the Company's sales and profitability, in the second half of the year, and a stabilization of supply may not emerge until the fourth quarter. The Company expects adverse cost development from rising raw material prices through the remainder of 2021.

1) This report includes content supplied by IHS Markit Automotive; Copyright © Light Vehicle Production Forecast, June, 2021. All rights reserved.

Non-U.S. GAAP financial measures

Some of the following discussions refer to non-U.S. GAAP financial measures: see reconciliations for "Organic sales", "Trade working capital", "Net debt", “Leverage ratio”, “Adjusted operating income”, “Adjusted operating margin” and “Adjusted EPS” provided below. Management believes that these non-U.S. GAAP financial measures provide supplemental information to investors regarding the performance of the Company’s business and assist investors in analyzing trends in the Company's business. Additional descriptions regarding management’s use of these financial measures are included below. Investors should consider these non-U.S. GAAP financial measures in addition to, rather than as substitutes for, financial reporting measures prepared in accordance with U.S. GAAP. These historical non-U.S. GAAP financial measures have been identified as applicable in each section of this report with a

19

tabular presentation reconciling them to the most directly comparable U.S. GAAP financial measures. It should be noted that these measures, as defined, may not be comparable to similarly titled measures used by other companies.

RESULTS OF OPERATIONS

Overview

The following table shows some of the key ratios management uses internally to analyze the Company's current and future financial performance and core operations as well as to identify trends in the Company’s financial conditions and results of operations. We have provided this information to investors to assist in meaningful comparisons of past and present operating results and to assist in highlighting the results of ongoing core operations. These ratios are more fully explained below and should be read in conjunction with the consolidated financial statements in our Annual Report on Form 10-K and the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

KEY RATIOS

(Dollars in millions, except per share data)

	Three months ended					Six months ended
	or as of June 30					or as of June 30
	2021		2020			2021		2020
Total parent shareholders’ equity per share	$	29.72	$	22.24		$	29.72	$	22.24
Capital employed 1)		3,815		3,793			3,815		3,793
Net debt 2)		1,200		1,838			1,200		1,838
Trade working capital8)		1,495		1,322			1,495		1,322
Trade working capital relative to sales, %9)		18.5		31.5			18.5		31.5
Receivables outstanding relative to sales, %10)		21.3		28.1			21.3		28.1
Inventory outstanding relative to sales, %11)		11.1		18.1			11.1		18.1
Payables outstanding relative to sales, %12)		13.9		14.7			13.9		14.7
Gross margin, % 3)		19.0		1.4			19.8		11.9
Operating margin, % 4)		8.1		(22.3	)		9.4		(3.4	)
Return on total equity, % 5)		16.3		(34.9	)		20.8		(9.7	)
Return on capital employed, % 6)		17.7		(25.0	)		21.8		(5.3	)
Headcount at period-end 7)		64,500		61,800			64,500		61,800

1) Total equity and net debt.

2) Net debt adjusted for pension liabilities in relation to EBITDA. See tabular presentation reconciling this non-U.S. GAAP measure to U.S. GAAP below.

3) Gross profit relative to sales.

4) Operating income relative to sales.

5) Net income relative to average total equity.

6) Operating income and income from equity method investments, relative to average capital employed.

7) Employees plus temporary, hourly personnel.

8) See calculation of this non-U.S. GAAP measure in the table below.

9) Outstanding working capital relative to annualized sales.

10) Outstanding receivables relative to annualized quarterly sales.

11) Outstanding inventory relative to annualized quarterly sales.

12) Outstanding payables relative to annualized quarterly sales.

20

THREE MONTHS ENDED JUNE 30, 2021 COMPARED WITH THREE MONTHS ENDED JUNE 30, 2020

Consolidated Sales

(dollars in millions)

	Three months ended June 30							Components of change in net sales
	2021		2020		Reported change			Currency effects 1)			Organic 3)
Airbag products and Other2)	$	1,310	$	654		100	%		7.5	%		92.9	%
Seatbelt products 2)		712		394		80.9	%		9.1	%		71.7	%
Total	$	2,022	$	1,048		93.0	%		8.1	%		84.9	%
Asia	$	794	$	588		35.1	%		6.6	%		28.5	%
Whereof: China		399		366		9.0	%		9.3	%		(0.3	)%
Japan		175		105		67.4	%		(3.9	)%		71.3	%
Rest of Asia		219		117		87.9	%		7.4	%		80.4	%
Americas		621		213		191	%		9.7	%		181	%
Europe		608		246		147	%		10.4	%		136	%
Total	$	2,022	$	1,048		93.0	%		8.1	%		84.9	%

1) Effects from currency translations.

2) Including Corporate and Other sales.

3) Non-U.S. GAAP measure.

Sales by product - Airbags

All major product categories within airbags grew strongly organically (Non-U.S. GAAP measure) in the quarter. The largest contributor to growth was inflatable curtains and steering wheels, followed by passenger airbags, driver airbags and side airbags. The highest growth rate was in knee airbags and steering wheels, with both growing by more than 100%.

Sales by product - Seatbelts

The main contributor to seatbelt products organic growth (Non-U.S. GAAP measure) was Europe and Americas. Seatbelt products grew organically in all major regions except China.

Sales by region

The Company's global organic sales (Non-U.S. GAAP measure, see reconciliation table above) grew by 85% compared to the LVP growth of 52% (according to IHS Markit June 2021). The more than 33pp outperformance was largely due to product launches and positive geographical mix effects as LVP in higher content per vehicle markets such as Europe and North America grew more than lower CPV markets such as China and Rest of Asia. The Company also saw positive vehicle mix effects within several regions. All regions except Rest of Asia outperformed LVP by 4-38pp. LVP grew in all regions except China, which declined by 4.6% as domestic OEMs grew by 9% and global OEMs declined by 14%.

Q2 2021 organic growth1)

Americas

Europe

China

Japan

Rest of Asia

Global

Autoliv

181

%

136

%

(0.3

)%

71

%

80

%

85

%

Main growth drivers

Stellantis, Honda, Nissan

VW, Stellantis, Daimler

GM, Geely, Xpeng

Toyota, Mitsubishi, Mazda

Hyundai/Kia, Suzuki, Mitsubishi

Stellantis, Toyota, VW

Main decline drivers

n/a

n/a

VW, Nissan, Hyundai/Kia

Honda

SsangYong, Renault

SsangYong

1) Non-U.S. GAAP measure.

21

Light Vehicle Production Development

Change second quarter of 2021 vs. second quarter of 2020

	Americas			Europe			China			Japan			Rest of Asia			Global
LVP1)		159	%		98	%		(4.6	)%		52	%		99	%		52	%
1) Source: IHS Markit June 2021.

Earnings

	Three months ended June 30
(Dollars in millions, except per share data)	2021			2020			Change
Net Sales	$	2,022		$	1,048			93.0	%
Gross profit		384			14			2,568	%
% of sales		19.0	%		1.4	%		17.6	pp
S, G&A		(111	)		(98	)		12.8	%
% of sales		(5.5	)%		(9.4	)%		(3.9)pp
R, D&E, net		(107	)		(88	)		21.3	%
% of sales		(5.3	)%		(8.4	)%		(3.1)pp
Amortization of Intangibles		(3	)		(2	)		5.4	%
Other income (expense), net		0			(59	)	n/a
Operating income (loss)		164			(234	)	n/a
% of sales		8.1	%		(22.3	)%		30.4	pp
Adjusted operating income (loss)1)		166			(172	)	n/a
% of sales		8.2	%		(16.4	)%		24.6	pp
Financial and non-operating items, net		(12	)		(13	)		(10.0	)%
Income (loss) before taxes		152			(247	)	n/a
Tax rate		31.3	%		29.3	%		2.0	pp
Net income (loss)		105			(174	)	n/a
Earnings (loss) per share, diluted2)		1.19			(2.00	)	n/a
Adjusted earnings (loss) per share, diluted1),2)		1.20			(1.40	)	n/a

1) Non-U.S. GAAP measure, excluding costs for capacity alignment.

2) Assuming dilution, when applicable, and net of treasury shares. Participating share awards with right to receive dividend equivalents are under the two-class method excluded from the EPS calculation.

Second quarter 2021 development

Gross profit increased by $370 million and the gross margin increased by 17.6pp compared to the same quarter 2020. The gross margin increase was primarily driven by the higher sales and direct material and labor productivity.

S,G&A costs increased by $13 million compared to the prior year, mainly relating to higher personnel costs due to extensive furloughing the prior year. In relation to sales, S,G&A costs decreased from 9.4% to 5.5%.

R,D&E, net costs increased by $19 million compared to the prior year, mainly relating to higher personnel costs due to extensive furloughing the prior year, and adverse foreign currency effects. In relation to sales, R,D&E costs declined from 8.4% to 5.3%.

Other income (expense), net improved by $59 million compared to prior year, mainly due to $61 million lower capacity alignment accruals.

Operating income (loss) improved by $398 million compared to the same period in 2020, mainly as a consequence of the higher gross profit and lower capacity alignment accruals, partially offset by higher costs for S,G&A and R,D&E, net.

Adjusted operating income (loss) (Non-U.S. GAAP measure) improved by $337 million compared to the prior year, mainly due to higher gross profit partially offset by higher costs for S,G&A and R,D&E, net.

Financial and non-operating items, net, were close to unchanged versus the prior year.

22

Income (loss) before taxes increased by $399 million compared to the prior year, mainly due to the higher operating income.

Tax rate was 31.3%, compared to 29.3% in the same quarter last year, mainly due to unfavorable country mix.

Earnings per share, diluted increased by $3.19 compared to a year earlier, where the main drivers were $2.90 from higher adjusted operating income (Non-U.S. GAAP measure) and $0.59 from lower capacity alignment costs partially offset by $0.31 from higher tax.

SIX MONTHS ENDED JUNE 30, 2021 COMPARED WITH SIX MONTHS ENDED JUNE 30, 2020

Consolidated Sales

(dollars in millions)

	Six months ended June 30							Components of change in net sales
	2021		2020		Reported change			Currency effects 1)			Organic 3)
Airbag products and Other 2)	$	2,773	$	1,856		49.4	%		4.6	%		44.8	%
Seatbelt products 2)		1,491		1,037		43.8	%		6.3	%		37.4	%
Total	$	4,265	$	2,893		47.4	%		5.2	%		42.2	%
Asia	$	1,671	$	1,185		41.0	%		5.7	%		35.3	%
Whereof: China		814		564		44.3	%		8.7	%		35.5	%
Japan		386		308		25.5	%		0.6	%		25.0	%
Rest of Asia		471		314		50.3	%		5.1	%		45.2	%
Americas		1,307		886		47.6	%		1.2	%		46.5	%
Europe		1,287		823		56.4	%		8.9	%		47.5	%
Total	$	4,265	$	2,893		47.4	%		5.2	%		42.2	%

1) Effects from currency translations.

2) Including Corporate and Other sales.

3) Non-U.S. GAAP measure.

Sales by product - Airbags

All major product categories within airbags grew strongly organically (Non-U.S. GAAP measure) in the first half of the year. The largest contributor to growth was inflatable curtains and steering wheels, followed by passenger airbags, driver airbags and side airbags.

Sales by product - Seatbelts

All regions except Japan, which was close to unchanged, showed a strong organic (Non-U.S. GAAP measure) seatbelt sales growth between 34% and 45%.

Sales by region

The global organic sales growth (Non-U.S. GAAP measure, see reconciliation table above) of 42% was 12pp better than LVP (according to IHS Markit June 2021). Sales increased organically in all regions. The largest organic sales increase drivers were Americas and Europe, followed by China, Rest of Asia and Japan. Our organic sales development outperformed LVP in all regions - by 15pp in Europe, by 10pp in China and Japan, by 9pp in Americas, and by 5pp in Rest of Asia.

First six months 2021 Organic growth1)

Americas

Europe

China

Japan

Rest of Asia

Global

Autoliv

46

%

47

%

36

%

25

%

45

%

42

%

Main growth drivers

Stellantis, Toyota, Honda

VW, Stellantis, BMW

GM, Great Wall, Honda

Toyota, Nissan, Mitsubishi

Hyundai/Kia, Suzuki, Mitsubishi

Stellantis, Toyota, VW

Main decline drivers

n/a

n/a

Hyundai/Kia, Daimler, Mazda

Honda

SsangYong, Renault

SsangYong

23

1) Non-U.S. GAAP measure.

Light Vehicle Production Development

Change vs. same period last year

	Americas			Europe			China			Japan			Rest of Asia			Global
LVP1)		37	%		32	%		25	%		15	%		40	%		30	%
1) Source: IHS Markit June 2021.

Earnings

	Six months ended June 30
(Dollars in millions, except per share data)	2021			2020			Change
Net Sales	$	4,265		$	2,893			47.4	%
Gross profit		843			345			144	%
% of sales		19.8	%		11.9	%		7.9	pp
S, G&A		(219	)		(192	)		13.9	%
% of sales		(5.1	)%		(6.6	)%		(1.5)pp
R, D&E, net		(213	)		(191	)		12.0	%
% of sales		(5.0	)%		(6.6	)%		(1.6)pp
Amortization of Intangibles		(5	)		(5	)		0.3	%
Other income (expense), net		(4	)		(57	)		(92.6	)%
Operating income (loss)		401			(99	)	n/a
% of sales		9.4	%		(3.4	)%		12.8	pp
Adjusted operating income (loss)1)		403			(36	)	n/a
% of sales		9.4	%		(1.2	)%		10.6	pp
Financial and non-operating items, net		(32	)		(36	)		(12.2	)%
Income (loss) before taxes		370			(135	)	n/a
Tax rate		29.2	%		26.5	%		2.7	pp
Net income (loss)		262			(99	)	n/a
Earnings (loss) per share, diluted2)		2.98			(1.14	)	n/a
Adjusted earnings (loss) per share, diluted1),2)		2.99			(0.53	)	n/a

1) Non-U.S. GAAP measure, excluding costs for capacity alignment.

2) Assuming dilution, when applicable, and net of treasury shares. Participating share awards with right to receive dividend equivalents are under the two-class method excluded from the EPS calculation.

First six months 2021 development

Gross profit increased by $497 million and the gross margin increased by 7.9pp compared to the same period 2020. The gross margin increase was primarily driven by higher sales and direct material and labor productivity.

S,G&A increased by $27 million, mainly relating to higher personnel costs due to extensive furloughing the prior year, and adverse foreign currency effects. In relation to sales, S,G&A costs decreased from 6.6% to 5.1%.

R,D&E, net increased by $23 million mainly due to higher personnel costs due to extensive furloughing the prior year, and adverse foreign currency effects. In relation to sales, R,D&E costs declined from 6.6% to 5.0%.

Other income (expense), net improved by $53 million compared to a year earlier, mainly due to $63 million in lower capacity alignment accruals, partly offset by adverse effects from foreign currency effects and lower government income.

Operating income (loss) improved by $500 million, mainly as a consequence of the increase in gross profit and other income (expense), net, partly offset by higher costs for S,G&A and R,D&E, net.

Adjusted operating income (loss) (Non-U.S. GAAP measure) improved by $438 million, mainly due to the higher gross profit, partly offset by higher costs for S,G&A and R,D&E, net.

24

Financial and non-operating items, net improved by around $4 million to $32 million, mainly due to higher income from equity method investments and foreign currency effects.

Income (loss) before taxes improved by $505 million, mainly as a consequence of higher operating income.

Tax rate was 29.2%, compared to 26.5% the prior year, impacted by unfavorable country mix.

Earnings per share, diluted increased by $4.12 where the main drivers were $4.06 from higher adjusted operating income (Non-U.S. GAAP measure) and $0.60 from lower capacity alignment costs partly mitigated by $0.57 from higher tax.

LIQUIDITY AND CAPITAL RESOURCES

Second quarter 2021 development

Trade working capital (Non-U.S. GAAP measure, see calculation below) increased by $173 million compared to the same period last year, mainly related to increased inventories as a consequence of higher sales, the low demand visibility and supply chain challenges. Compared to the first quarter of 2021, trade working capital increased by $8 million.

Operating cash flow increased by $191 million to $63 million. The improvement was mainly due to positive effects from higher net income and deferred income taxes. Operating cash flow in the quarter was impacted negatively by effects from changes in operating working capital, mainly relating to tax, recalls and insurance while effects from trade working capital was limited.

Capital expenditures, net increased by 51%, supporting the organic growth. Capital expenditures, net in relation to sales was 4.8% vs. 6.1% a year earlier.

Cash flow from operations less capital expenditures, net amounted to negative $33 million, compared to negative $192 million a year earlier. The improvement was due to the higher operating cash flow, partially offset by the higher capital expenditures, net.

Net debt (Non-U.S. GAAP measure, see reconciliation table below) was $1,200 million as of June 30, 2021, which was $638 million lower than a year earlier and $85 million higher compared to March 31, 2021.

Liquidity position. At June 30, 2021, the cash balance was $0.9 billion, and including committed, unused loan facilities, the Company's liquidity position was $2.0 billion.

Leverage ratio (Non-U.S. GAAP measure, see calculation below). As of June 30, 2021, the Company had a leverage ratio of 1.1x, compared to 2.8x at June 30, 2020 as the net debt decreased substantially and the 12 months trailing adjusted EBITDA (Non-U.S. GAAP measure) increased substantially.

Total equity increased by $660 million compared to June 30, 2020 mainly due to $550 million from net income and $146 million from currency translation effects partially offset by dividend payments of $55 million.

First six months 2021 development

Operating cash flow was $249 million compared to $28 million a year earlier. The increase of $221 million was primarily due to positive effects of the higher net income and deferred income taxes, partly offset by negative effects from changes in operating working capital.

Capital expenditure, net of $189 million was 24% higher than a year earlier, reflecting our efforts to reduce capital expenditure to support cash flow in the first half of 2020. Capital expenditure, net in relation to sales was 4.4% compared to 5.3% in the same period 2020.

Cash flow from operations less capital expenditures, net amounted to $60 million compared to negative $124 million a year earlier, driven by the improvement in operating cash flow, partially offset by a higher capital expenditure, net.

25

NON-U.S. GAAP MEASURES

Reconciliation of U.S. GAAP financial measures to “Adjusted operating income”, “Adjusted operating margin” and “Adjusted EPS”

(Dollars in millions, except per share data)

	Three months ended June 30, 2021						Three months ended June 30, 2020
	Reported U.S. GAAP		Adjustments1)		Non-U.S. GAAP		Reported U.S. GAAP			Adjustments1)		Non-U.S. GAAP
Operating income (loss)	$	164	$	1	$	166	$	(234	)	$	62	$	(172	)
Operating margin, %		8.1		0.1		8.2		(22.3	)		5.9		(16.4	)
Earnings (loss) per share, diluted		1.19		0.01		1.20		(2.00	)		0.60		(1.40	)

1) Including costs for capacity alignment.

	Six months ended June 30, 2021						Six months ended June 30, 2020
	Reported U.S. GAAP		Adjustments1)		Non-U.S. GAAP		Reported U.S. GAAP			Adjustments1)		Non-U.S. GAAP
Operating income (loss)	$	401	$	1	$	403	$	(99	)	$	64	$	(36	)
Operating margin, %		9.4		0.0		9.4		(3.4	)		2.2		(1.2	)
Earnings (loss) per share, diluted		2.98		0.01		2.99		(1.14	)		0.61		(0.53	)

1) Including costs for capacity alignment.

Items included in Non-U.S. GAAP adjustments

(Dollars in millions, except per share data)

	Three months ended June 30, 2021				Three months ended June 30, 2020
	Millions		Per share		Millions			Per share
Capacity alignment	$	1	$	0.02	$	62		$	0.71
Total adjustments to operating income		1		0.02		62			0.71
Tax on non-U.S. GAAP adjustments1)		0		0.00		(10	)		(0.11	)
Total adjustments to net income	$	1	$	0.01	$	52		$	0.60

1) The tax is calculated based on the tax laws in the respective jurisdiction(s) of the adjustment(s).

	Six months ended June 30, 2021				Six months ended June 30, 2020
	Millions		Per share		Millions			Per share
Capacity alignment	$	1	$	0.02	$	64		$	0.73
Total adjustments to operating income		1		0.02		64			0.73
Tax on non-U.S. GAAP adjustments1)		0		0.00		(10	)		(0.12	)
Total adjustments to net income	$	1	$	0.01	$	54		$	0.61

1) The tax is calculated based on the tax laws in the respective jurisdiction(s) of the adjustment(s).

26

The Company uses the non-U.S. GAAP measure “Trade working capital,” as defined in the table below, in its communications with investors and for management’s review of the development of the trade working capital cash generation from operations. The reconciling items used to derive this measure are, by contrast, managed as part of the Company’s overall cash and debt management, but they are not part of the responsibilities of day-to-day operations’ management.

Calculation of “Trade working capital”

(Dollars in millions)

	June 30, 2021			December 31, 2020			June 30 2020
Receivables, net	$	1,719		$	1,822		$	1,180
Inventories, net		901			798			758
Accounts payable		(1,125	)		(1,254	)		(616	)
Trade working capital	$	1,495		$	1,366		$	1,322

The non-U.S. GAAP measure net debt is also used in the non-U.S. GAAP measure “Leverage ratio”. Management uses this measure to analyze the amount of debt the Company can incur under its debt policy. Management believes that this policy also provides guidance to credit and equity investors regarding the extent to which the Company would be prepared to leverage its operations. For details on leverage ratio refer to the table below.

Reconciliation of U.S. GAAP financial measure to “Net debt”

(Dollars in millions)

	June 30, 2021			December 31, 2020			June 30, 2020
Short-term debt	$	363		$	302		$	493
Long-term debt		1,712			2,110			2,567
Total debt		2,075			2,411			3,060
Cash and cash equivalents		(893	)		(1,178	)		(1,223	)
Debt issuance cost/Debt-related derivatives, net		18			(19	)		1
Net debt	$	1,200		$	1,214		$	1,838

In 2021, the EBITDA calculation was redefined to exclude other non-operating items and income from equity method investments. EBITDA and Leverage ratio in prior periods have been recalculated resulting in minor adjustments. The Company's policy is to maintain a leverage ratio commensurate with a strong investment grade credit rating. The Company measures its leverage ratio as net debt adjusted for pension liabilities in relation to adjusted EBITDA. The long-term target is to maintain a leverage ratio of around 1.0x within a range of 0.5x to 1.5x.

Calculation of “Leverage ratio”

(Dollars in millions)

	June 30, 2021			December 31, 2020			June 30, 2020
Net debt1)	$	1,200		$	1,214		$	1,838
Pension liabilities		239			248			236
Debt per the Policy		1,438			1,462			2,074
Net income2)		550			188			142
Income taxes 2)		247			103			66
Interest expense, net2,3)		69			68			62
Other non-operating items, net2)		22			25			14
Income from equity method investments2)		(4	)		(2	)		(1	)
Depreciation and amortization of intangibles2)		394			371			350
Capacity alignments and separation costs2), 4)		37			99			105
EBITDA per the Policy (Adjusted EBITDA)	$	1,313		$	852		$	739
Leverage ratio		1.1			1.7			2.8

1) Net debt (non-U.S. GAAP measure) is short- and long-term debt and debt-related derivatives, less cash and cash equivalents.

2) Latest 12-months.

3) Interest expense, net including cost for extinguishment of debt, if any, less interest income.

27

4) No separation costs included in latest 12-months as of June 30, 2021 and December 31, 2020. In latest 12-months as of June 30, 2020, separation costs amounted to $1 million.

Headcount

	June 30, 2021			March 31, 2021			June 30, 2020
Total headcount		64,500			66,600			61,800
Whereof:
Direct personnel in manufacturing		46,400			48,700			43,400
Indirect personnel		18,000			17,900			18,400
Temporary personnel		9	%		10	%		6	%

By June 30, 2021, total headcount increased by 2,700 compared to a year earlier, reflecting a significant increase in production. The direct workforce increased by around 7% while the indirect workforce declined by around 2%. Compared to March 31, 2021, total headcount decreased by around 3.1%. This was driven by a decrease of around 4.6% of the direct workforce reflecting a lower LVP, while the indirect workforce increased by 0.8%.

Full year 2021 indications

The Company's outlook indications for 2021 reflect continuing uncertainty in the automotive markets and are mainly based on our customer call-offs and global LVP outlook according to IHS Markit, indicating a full year 2021 global LVP growth of 9-11%.

Financial measure	Full year indication
Net sales growth	Around 20-22%
Organic sales growth	Around 16-18%
Adjusted operating margin 1)	Around 9-9.5%
R,D&E, net % of sales	Around 4.5%
Tax rate 2)	Around 30%
Operating cash flow 3)	Similar level as 2020
Capex, net % of sales	Below 6%
Organic growth vs LVP growth	Around +7pp
1) Excluding costs for capacity alignments and antitrust related matters.
2) Excluding unusual tax items.
3) Excluding unusual items.

The forward-looking non-U.S. GAAP financial measures above are provided on a non-U.S. GAAP basis. The Company has not provided a U.S. GAAP reconciliation of these measures because items that impact these measures, such as costs related to capacity alignments and antitrust matters, cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and the Company is unable to determine the probable significance of the unavailable information.

OFF-BALANCE SHEET ARRANGEMENTS

The Company does not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on its financial position, results of operations or cash flows.

CONTRACTUAL OBLIGATIONS AND COMMITMENTS

The Company’s future contractual obligations have not changed materially from the amounts reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 19, 2021.

28

OTHER RECENT EVENTS

Key launches in the second quarter of 2021

Toyota Land Cruiser 300: Side Airbags, Head/Inflatable Curtain Airbags and Seatbelts.

Nissan Pathfinder: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Front Center Airbag and Knee Airbag.

Skoda Fabia: Side Airbags, Head/Inflatable Curtain Airbags and Seatbelts.

Mercedes EQS: Steering Wheel, Driver/Passenger Airbags and Bag-in-Belt.

Zeekr 001: Steering Wheel, Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Seatbelts and Front Center Airbag.

Chevrolet Bolt EUV: Steering Wheel, Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags and Seatbelts

WEY Macchiato: Steering Wheel, Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Seatbelts, Hood Lifter, Front Center Airbag and Knee Airbag.

Citroën C5X: Steering Wheel, Driver/Passenger Airbags, Head/Inflatable Curtain Airbags, Seatbelts and Hood Lifter.

Renault Kangoo: Side Airbags, Head/Inflatable Curtain Airbags and Seatbelts.

Other Items

On May 12, 2021, Autoliv announced that its Board of Directors decided to reinstate quarterly dividends and declared a quarterly dividend of $0.62 per share for the second quarter of 2021. "Although the COVID-19 pandemic is not yet behind us, the significant improvement in profitability and free cash flow generation over the recent quarters shows that we have built a solid platform towards our mid-term financial targets” said Jan Carlson, Chairman of the Board of Directors. “It is our ambition to consistently create competitive shareholder value through our purpose-led strategy and operations and I am happy that we can now reinstate our quarterly dividend.” continued Mr. Carlson.

On May 18, 2021, Autoliv announced plans to construct a new steering wheel manufacturing plant in Aguascalientes, Mexico. When fully operational, the 30,000 sqm/322,000 sq ft facility will have the potential to employ up to 3,000 people. “We are doing this expansion to meet growing customer demand,” said Kevin Fox, President, Autoliv Americas. “This new facility, along with our Matamoros, Mexico facility, will allow us to continue to provide world-class support to our customers. This investment will increase capacity but it will also allow us to optimize our manufacturing processes at both facilities and it will create exciting opportunities for our team members in Mexico,” continued Mr. Fox.

On June 17, 2021, Autoliv announced ambitious climate targets including its plan to become carbon neutral in its own operations by 2030, aims for net-zero emissions across its supply chain by 2040, and its commitment to the Science Based Targets initiative.

29

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As of June 30, 2021, there have been no material changes to the information related to quantitative and qualitative disclosures about market risk that was provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 19, 2021.

ITEM 4. CONTROLS AND PROCEDURES

(a)Evaluation of Disclosure Controls and Procedures

An evaluation has been carried out, under the supervision and with the participation of the Company's management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company's disclosure controls and procedures are effective.

(b)Changes in Internal Control over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

30

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

In the ordinary course of our business, we are subject to legal proceedings brought by or against us and our subsidiaries. 

See Part I, Item 1, "Financial Statements, Note 9 Contingent Liabilities" of this Quarterly Report on Form 10-Q for a summary of certain ongoing legal proceedings. Such information is incorporated into this Part II, Item 1—"Legal Proceedings" by reference.

ITEM 1A. RISK FACTORS

Except as set forth below, as of June 30, 2021, there have been no material changes to the risk factors that were previously disclosed in Item 1A in the Company’s Form 10-K for the year ended December 31, 2020 filed with the SEC on February 19, 2021.

You should not anticipate or expect the payment of cash dividends on our common stock

Our dividend policy is subject to the discretion of our Board of Directors and depends upon a number of factors, including our earnings, financial condition, cash and capital needs, indebtedness and leverage, and general economic or business conditions. On April 2, 2020, our Board of Directors suspended our quarterly dividend after determining that a suspension was necessary in light of the evolving global COVID-19 pandemic, decline in global LVP, the uncertainty surrounding the recession at that time and the inherent risk of customer defaults. On May 12, 2021, we announced that our Board of Directors reinstated our quarterly dividend for the second quarter of 2021. There can be no assurance that our Board of Directors will declare dividends in the future.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Stock repurchase program

During the six months ended June 30, 2021, the Company made no stock repurchases. The Company is authorized to purchase up to 47.5 million shares of common stock under its stock repurchase program, which was first approved by the Board of Directors of the Company on May 9, 2000. Under the existing authorization, 2,986,288 shares may be repurchased. The stock repurchase program does not have an expiration date.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

31

ITEM 6. EXHIBITS

Exhibit No.	Description
3.1	Autoliv’s Restated Certificate of Incorporation, as amended, incorporated herein by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 22, 2015).
3.2	Autoliv’s Third Restated By-Laws incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 001-12933, filing date December 18, 2015).
4.1	Indenture, dated March 30, 2009, between Autoliv, Inc. and U.S. Bank National Association, as trustee, incorporated herein by reference to Exhibit 4.1 to Autoliv’s Registration Statement on Form 8-A (File No. 001-12933, filing date March 30, 2009).
4.2	Second Supplemental Indenture (including Form of Global Note), dated March 15, 2012, between Autoliv, Inc. and U.S. Bank National Association, as trustee, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-12933, filing date March 15, 2012).
4.3	Form of Note Purchase and Guaranty Agreement dated April 23, 2014, among Autoliv ASP, Inc., Autoliv, Inc. and the purchasers named therein, incorporated herein by reference to Exhibit 4.6 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 25, 2014).
4.4	Amendment and Waiver 2014 Note Purchase and Guaranty Agreement, dated May 24, 2018, among Autoliv, Inc., Autoliv ASP, Inc. and the noteholders named therein, incorporated herein by reference to Exhibit 4.4 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date July 27, 2018).
4.5	General Terms and Conditions for Swedish Depository Receipts in Autoliv, Inc. representing common shares in Autoliv, Inc., effective as of May 30, 2018, with Skandinaviska Enskilda Banken AB (publ) serving as a custodian, incorporated herein by reference to Exhibit 4.5 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date July 27, 2018).
4.6	Agency Agreement dated June 26, 2018 among Autoliv, Inc., Autoliv ASP, Inc. and HSBC Bank PLC, incorporated herein by reference to Exhibit 4.6 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date July 27, 2018).
4.7	Base Listing Particulars Agreement, dated April 11, 2019, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein., incorporated herein by reference to Exhibit 4.7 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 26, 2019).
4.8	Base Listing Particulars Agreement, dated February 21, 2020, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein, incorporated herein by reference to Exhibit 4.10 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 24, 2020).
4.9	Base Listing Particulars Agreement, February 19, 2021, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein, incorporated herein by reference to Exhibit 4.13 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 23, 2021).
4.10	Amended and Restated Programme Agreement, dated February 19, 2021, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein, incorporated herein by reference to Exhibit 4.14 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 23, 2021).
4.11	Amended and Restated Agency Agreement, dated February 19, 2021, among Autoliv, Inc., Autoliv ASP, Inc. and the dealers named therein. incorporated herein by reference to Exhibit 4.15 to the Quarterly Report on Form 10-Q (File No. 001-12933, filing date April 23, 2021).
10.1*+	Form of Non-Employee Directors 2021 restricted stock units grant agreement under Autoliv, Inc. 1997 Stock Incentive Plan, as amended and restated.
31.1*	Certification of the Chief Executive Officer of Autoliv, Inc. pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.
31.2*	Certification of the Chief Financial Officer of Autoliv, Inc. pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.
32.1*	Certification of the Chief Executive Officer of Autoliv, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32

32.2*	Certification of the Chief Financial Officer of Autoliv, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document – The instance document does not appear in the Interactive Date File because its XBRL tags are embedded within the inline XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*	Cover Page Interactive Data File (embedded within the inline XBRL document).

* Filed herewith.

+ Management contract or compensatory plan.

33

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: July 16, 2021

AUTOLIV, INC.

(Registrant)

By:	/s/ Fredrik Westin
	Fredrik Westin
	Chief Financial Officer
	(Duly Authorized Officer and Principal Financial Officer)

34

EX-10.1

Exhibit 10.1

Exhibit 10.1

2021 RESTRICTED STOCK UNITS GRANT AGREEMENT

For Non-Employee Directors

Applicable to Restricted Stock Units promised under the Autoliv, Inc. 1997 Stock IncentivePlan

(as amended and restated)

Your above-described grant of restricted stock units (“RSUs”) is subject to the following provisions in addition to those set forth in the attached Notice of Grant (the “Grant Notice”) and the Autoliv, Inc. 1997 Stock Incentive Plan, as amended and restated (the “Plan”):

1.Defined Terms: Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan.

2.Vesting: The RSUs have been credited to a bookkeeping account (“Account”) on your behalf as of the grant date specified in the Grant Notice (the “Grant Date”). Your Account will reflect the number of RSUs awarded to you as set forth in the Grant Notice, as well as any additional RSUs credited as a result of dividend equivalents, as described in Section 9 below. Each RSU represents an unfunded, unsecured right to receive Common Stock, subject to the terms and conditions stated in the Plan and this Grant Agreement. Your RSUs will vest and become non-forfeitable on the earliest to occur of the following (each, a “Date of Vesting”):

(a)as to all of the RSUs, on the Date of Vesting specified in the Grant Notice, provided that you are then still providing services as a member of the Board of Directors of the Company (the “Board”); or

(b)as to all of the RSUs, upon the occurrence of a Change in Control as described in Section 5 below, provided that you are then still providing services as a member of the Board.

(c)as to all of RSUs, upon death or disability.

If your service on the Board terminates for any reason other than death, disability, or a Change-in-Control as described in Section 5, you will forfeit all right, title and interest in and to the unvested RSUs as of the date of such termination, and the unvested RSUs will be re-conveyed to the Company without further consideration or any act or action by you.

1

Exhibit 10.1

6.Conversion to Shares of Common Stock; Procedure at Date of Vesting:

a.Unless the RSUs are forfeited prior to the Date of Vesting as provided in Section 2 above, the RSUs will be converted on the Date of Vesting to actual shares of Common Stock. The shares of Common Stock to be issued pursuant to this Grant Agreement

shall be issued in the form of book-entry shares of Common Stock in your name as the beneficial owner as of the Date of Vesting.

b.You will, if requested, within the specified time set forth in any such request (not to exceed 30 days), deliver to the Company such written representations and undertakings as may, in the opinion of the Company’s legal counsel, be necessary or desirable to comply with tax and securities laws.

7.Securities Law Restrictions; Insider Trading Policy:

You may not offer, sell or otherwise dispose of any shares of Common Stock in a manner which would violate any applicable laws, including, without limitation, the laws of Sweden, U.S. federal and state securities laws, U.S. federal law, the requirements of any stock exchange or quotation system upon which the Common Stock may then be listed or quoted and any laws of any other country or jurisdiction that may be applicable to you.

In connection with receipt of this Grant Agreement, you acknowledge that you are subject to the Company’s AS 314 Insider Trading Policy which may be found in the “Director Library” within the board information portal (currently BoardVantage) and is also available upon request to the Legal department of the Company.

8.Change in Control of the Company:

Notwithstanding any provision herein to the contrary, your RSUs shall immediately vest in full under the following situations:

a.If (i) a Change in Control occurs prior to the Date of Vesting and while you are an Autoliv Board member, and (ii) the surviving entity is not a public company with shares listed on a public stock exchange, then as of the effective date of the Change in Control, RSUs shall immediately vest in full.

b.If (i) a Change in Control occurs prior to the Date of Vesting and while you are an Autoliv Board member, (ii) the RSUs are assumed and equitably converted by the surviving entity which is a publicly traded company with shares listed on a public stock exchange, and (iii) you will be asked to leave the Board by the Company without cause before the date of vesting, then as of your date of termination, your equitably converted RSUs shall immediately vest in full if they have not vested by that date.

2

Exhibit 10.1

9.Non-Transferability:

Your RSUs are personal to you and shall not be transferable by you otherwise than by will or the laws of descent and distribution.

10.Conformity with Plan:

Your RSUs are intended to conform in all respects with the Plan, including any future amendments thereto. Inconsistencies between this Grant Agreement and the Plan shall be

resolved in accordance with the terms of the Plan. All definitions stated in the Plan shall be fully applicable to this Grant Agreement.

11.Service and Successors:

Nothing herein or in the Grant Notice or in the Plan confers any right or obligation on you to continue providing services to the Company or shall affect in any way your right or the right of the Company or any subsidiary, as the case may be, to terminate your service at any time. This Grant Agreement, the Grant Notice and the Plan, including any future amendments thereto, shall be binding upon you, your estate, any person succeeding to your rights hereunder and any successor or successors of the Company. The RSUs do not confer to you or any person succeeding to your rights hereunder any rights of a shareholder of the Company unless and until shares of Common Stock are in fact issued to you or such person in connection with the settlement of the RSUs.

12.Dividend Equivalent Rights:

Subject to share availability under the Plan, any cash dividend paid with respect to the Common Stock for which the record date occurs on or after the Grant Date and the payment date occurs on or before the Date of Vesting will result in a credit to your Account of additional RSUs equal to (a) the dollar amount of the dividend per share of Common Stock multiplied by the number of RSUs credited to your Account as of the applicable record date, divided by (b) the closing price per share of the Common Stock on the New York Stock Exchange on the applicable dividend payment date. The additional RSUs credited pursuant to this Section 9 will be subject to the same vesting schedule, forfeiture and other terms that apply to the original RSUs. On the Date of Vesting, the aggregate number of any additional RSUs credited pursuant to this Section 9 over time shall be rounded down to the nearest whole share. RSUs that, at the relevant dividend payment date, previously have been settled or forfeited will not be eligible to receive dividend equivalents pursuant to this Section 9.

3

Exhibit 10.1

13.Tax:

You are totally responsible for paying all taxes that you incur in respect of this Grant Agreement. The Company has the authority and the right to deduct or withhold, or require you to remit, an amount sufficient to satisfy all applicable taxes required by law to be withheld with respect to any taxable event arising as a result of vesting or settlement of the RSUs. The withholding requirement may be satisfied, in whole or in part, by withholding from the settlement of the RSUs, shares of Common Stock having a fair market value on the date of withholding equal to the minimum amount (and not any greater amount unless such other withholding rate will not cause an adverse accounting consequence or cost) required to be withheld for tax purposes, all in accordance with such procedures as the Company establishes. The obligations of the Company hereunder will be conditional on such payment, and the Company will, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to you.

14.Governing Law:

This Grant Agreement, the Grant Notice and the Plan shall be construed in accordance with and governed by the laws of the State of Delaware, USA, and, to the extent relevant, the local laws of your home country.

15.Severability:

If any one or more of the provisions contained in this Grant Agreement are invalid, illegal or unenforceable, the other provisions of this Grant Agreement will be construed and enforced as if the invalid, illegal or unenforceable provision had never been included.

16.Director Stock Ownership Requirements:

In connection with receipt of this Grant Agreement, you acknowledge that you are subject to the Company’s policy regarding “Stock Ownership Policy for Directors”.

17.Fractional Shares:

No fractional shares of Common Stock, nor the cash value of any fractional shares of Common Stock, will be issuable or payable to you pursuant to this Agreement.

4

EX-31.1

Exhibit 31.1

CERTIFICATION of

the Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Mikael Bratt, certify that:

1.I have reviewed this quarterly report on Form 10-Q of AUTOLIV, INC.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

July 16, 2021

/s/ Mikael Bratt

Mikael Bratt

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION of

the Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Fredrik Westin, certify that:

1.I have reviewed this quarterly report on Form 10-Q of AUTOLIV, INC.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

July 16, 2021

/s/ Fredrik Westin

Fredrik Westin

Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report on Form 10-Q of Autoliv, Inc. (the “Company”) for the period ended June 30, 2021, filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mikael Bratt, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 16, 2021

/s/ Mikael Bratt

Mikael Bratt

President and Chief Executive Officer

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report on Form 10-Q of Autoliv, Inc. (the “Company”) for the period ended June 30, 2021, filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Fredrik Westin, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 16, 2021

/s/ Fredrik Westin

Fredrik Westin

Chief Financial Officer

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Jul. 12, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Trading Symbol	ALV
Security Exchange Name	NYSE
Entity Registrant Name	AUTOLIV, INC.
Entity Central Index Key	0001034670
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common Stock (par value $1.00 per share)
Entity Common Stock, Shares Outstanding		87,472,019
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity File Number	001-12933
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0378542
Entity Address, Address Line One	Klarabergsviadukten 70, Section B7
Entity Address, Address Line Two	Box 70381
Entity Address, City or Town	Stockholm
Entity Address, Country	SE
Entity Address, Postal Zip Code	SE-107 24
City Area Code	+46 8
Local Phone Number	587 20 600
Document Quarterly Report	true
Document Transition Report	false

XML

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net sales		$ 2,022	$ 1,048	$ 4,265	$ 2,893
Type of Revenue [Extensible List]		us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of sales		$ (1,638)	$ (1,033)	$ (3,422)	$ (2,548)
Type of Cost, Good or Service [Extensible List]		us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit		$ 384	$ 14	$ 843	$ 345
Selling, general and administrative expenses		(111)	(98)	(219)	(192)
Research, development and engineering expenses, net		(107)	(88)	(213)	(191)
Amortization of intangibles		(3)	(2)	(5)	(5)
Other income (expense), net		0	(59)	(4)	(57)
Operating income (loss)		164	(234)	401	(99)
Income from equity method investment		0	0	2	0
Interest income		2	1	2	3
Interest expense		(16)	(16)	(32)	(32)
Other non-operating items, net		2	1	(4)	(7)
Income (loss) before income taxes		152	(247)	370	(135)
Income tax (expense) benefit		(48)	72	(108)	36
Net income (loss)		105	(174)	262	(99)
Less: Net income attributable to non-controlling interest		0	0	1	0
Net income (loss) attributable to controlling interest		$ 104	$ (175)	$ 261	$ (100)
Net earnings (loss) per share - basic	[1]	$ 1.19	$ (2.00)	$ 2.98	$ (1.14)
Net earnings (loss) per share - diluted	[1]	$ 1.19	$ (2.00)	$ 2.98	$ (1.14)
Weighted average number of shares outstanding, net of treasury shares (in millions)	[2]	87.4	87.3	87.4	87.3
Weighted average number of shares outstanding, assuming dilution and net of treasury shares (in millions)		87.7	87.3	87.7	87.3
Cash dividend per share - declared	[3],[4]	$ 0.62	$ 0	$ 0.62	$ 0
Cash dividend per share – paid	[4]	$ 0.62	$ 0	$ 0.62	$ 0.62

[1] Participating share awards with the right to receive dividend equivalents are (under the two-class method) excluded from the earnings per share calculation (see Note 11 to the unaudited condensed consolidated financial statements).

[2] The Company’s unvested RSUs and PSUs, of which some included the right to receive non-forfeitable dividend equivalents, are considered participating securities. Calculations of EPS under the two-class method exclude from the numerator any dividends paid or owed on participating securities and any undistributed earnings considered to be attributable to participating securities. The related participating securities are similarly excluded from the denominator.

[3] As earlier communicated, on April 2, 2020, the Company announced it canceled its declared dividend for the second quarter of 2020.

[4] On May 12, 2021, the Company announced it will reinstate quarterly dividends and declared a dividend of 62 cents for the second quarter of 2021.

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 105	$ (174)	$ 262	$ (99)
Other comprehensive income (loss) before tax:
Change in cumulative translation adjustments	37	27	(27)	(75)
Net change in unrealized components of defined benefit plans	1	3	3	4
Other comprehensive income (loss), before tax	38	30	(24)	(71)
Tax effect allocated to other comprehensive loss	0	(1)	(1)	(1)
Other comprehensive income (loss), net of tax	38	29	(25)	(72)
Total comprehensive income (loss)	143	(145)	237	(172)
Less: Comprehensive income attributable to non-controlling interest	1	1	1	0
Comprehensive income (loss) attributable to controlling interest	$ 142	$ (146)	$ 236	$ (172)

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions		Jun. 30, 2021	Dec. 31, 2020
Assets
Cash and cash equivalents		$ 893	$ 1,178
Receivables, net		1,719	1,822
Inventories, net		901	798
Prepaid expenses and accrued income		230	164
Other current assets		60	307
Total current assets		3,804	4,269
Property, plant and equipment, net		1,833	1,869
Operating lease right-of-use assets		133	141
Goodwill		1,393	1,398
Intangible assets, net		11	14
Other non-current assets		462	466
Total assets		7,636	8,157
Liabilities and equity
Short-term debt	[1]	363	302
Accounts payable		1,125	1,254
Accrued expenses		1,066	1,270
Operating lease liabilities - current		39	37
Other current liabilities		260	284
Total current liabilities		2,852	3,147
Long-term debt	[1]	1,712	2,110
Pension liability		239	248
Operating lease liabilities - non-current		94	103
Other non-current liabilities		125	126
Total non-current liabilities		2,170	2,587
Common stock		103	103
Additional paid-in capital		1,329	1,329
Retained earnings		2,678	2,471
Accumulated other comprehensive loss		(372)	(347)
Treasury stock		(1,138)	(1,147)
Total controlling interest's equity		2,600	2,409
Non-controlling interest		15	14
Total equity		2,615	2,423
Total liabilities and equity		$ 7,636	$ 8,157

[1] Debt as reported in balance sheet.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Operating activities
Net income (loss)	$ 262	$ (99)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	199	175
Deferred income taxes	3	(101)
Other, net	(1)	28
Net change in operating assets and liabilities	(214)	25
Net cash provided by operating activities	249	28
Investing activities
Expenditures for property, plant and equipment	(191)	(154)
Proceeds from sale of property, plant and equipment	1	2
Net cash used in investing activities	(189)	(152)
Financing activities
Net decrease in short-term debt	(291)	(142)
Increase in long-term debt	14	1,720
Decrease in long-term debt	0	(630)
Dividends paid	(54)	(54)
Common stock options exercised	2	0
Net cash (used in) provided by financing activities	(329)	895
Effect of exchange rate changes on cash and cash equivalents	(16)	8
(Decrease) increase in cash and cash equivalents	(285)	779
Cash and cash equivalents at beginning of period	1,178	445
Cash and cash equivalents at end of period	$ 893	$ 1,223

XML

CONSOLIDATED STATEMENTS OF TOTAL EQUITY (UNAUDITED) - USD ($) $ in Millions		Total	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss	Treasury stock	Total controlling interest's equity	Non-controlling interest
Balance at Dec. 31, 2019		$ 2,122	$ 103	$ 1,329	$ 2,284	$ (449)	$ (1,158)	$ 2,109	$ 13
Comprehensive Income (loss):
Net income		75			75			75	0
Foreign currency translation adjustment		(102)				(102)		(102)	0
Pension liability		1				1		1
Total comprehensive income (loss)		(26)			75	(101)		(26)	0
Stock-based compensation		2					2	2
Cash dividends declared	[1]	(54)			(54)			(54)
Balance at Mar. 31, 2020		2,044	103	1,329	2,305	(550)	(1,156)	2,031	13
Balance at Dec. 31, 2019		2,122	103	1,329	2,284	(449)	(1,158)	2,109	13
Comprehensive Income (loss):
Net income		(99)
Total comprehensive income (loss)		(172)
Balance at Jun. 30, 2020		1,955	103	1,329	2,184	(521)	(1,154)	1,942	14
Balance at Mar. 31, 2020		2,044	103	1,329	2,305	(550)	(1,156)	2,031	13
Comprehensive Income (loss):
Net income		(174)			(175)			(175)	1
Foreign currency translation adjustment		27				27		27	0
Pension liability		2				2		2
Total comprehensive income (loss)		(145)			(175)	29		(146)	1
Stock-based compensation		2				0	2	2
Cash dividends declared - reversal	[1]	54			54			54
Balance at Jun. 30, 2020		1,955	103	1,329	2,184	(521)	(1,154)	1,942	14
Balance at Dec. 31, 2020		2,423	103	1,329	2,471	(347)	(1,147)	2,409	14
Comprehensive Income (loss):
Net income		157			157			157	0
Foreign currency translation adjustment		(64)				(64)		(64)	0
Pension liability		1				1		1
Total comprehensive income (loss)		94			157	(63)		94	0
Stock-based compensation		4					4	4
Balance at Mar. 31, 2021		2,521	103	1,329	2,628	(410)	(1,143)	2,507	14
Balance at Dec. 31, 2020		2,423	103	1,329	2,471	(347)	(1,147)	2,409	14
Comprehensive Income (loss):
Net income		262
Total comprehensive income (loss)		237
Balance at Jun. 30, 2021		2,615	103	1,329	2,678	(372)	(1,138)	2,600	15
Balance at Mar. 31, 2021		2,521	103	1,329	2,628	(410)	(1,143)	2,507	14
Comprehensive Income (loss):
Net income		105			104			104	1
Foreign currency translation adjustment		37				37		37	0
Pension liability		1				1		1
Total comprehensive income (loss)		143			104	38	0	142	1
Stock-based compensation		5					5	5	0
Cash dividends declared	[2]	(54)			(54)			(54)
Balance at Jun. 30, 2021		$ 2,615	$ 103	$ 1,329	$ 2,678	$ (372)	$ (1,138)	$ 2,600	$ 15

[1] Reversal of canceled dividend declared for the second quarter of 2020 which was announced by the Company on April 2, 2020.

[2] Dividend for the second quarter of 2021 was declared on May 12, 2021.

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Basis of Presentation

1. BASIS OF PRESENTATION

The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the prior year audited consolidated financial statements and all adjustments considered necessary for a fair presentation have been included in the consolidated financial statements. All such adjustments are of a normal recurring nature. The results for the interim period are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending December 31, 2021.

The Condensed Consolidated Balance Sheet at December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements.

The Company has one reportable segment, which includes Autoliv’s airbag and seatbelt products and components.

Certain amounts in the condensed consolidated financial statements and associated notes may not reconcile due to rounding. All percentages have been calculated using unrounded amounts. Certain amounts in prior periods have been reclassified to conform to current year presentation.

Statements in this report that are not of historical fact are forward-looking statements that involve risks and uncertainties that could affect the actual results of the Company. A description of the important factors that could cause Autoliv’s actual results to differ materially from the forward-looking statements contained in this report may be found in this report and Autoliv’s other reports filed with the Securities and Exchange Commission (the "SEC"). For further information, refer to the consolidated financial statements, footnotes and definitions thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 19, 2021.

XML

New Accounting Standards

6 Months Ended

Jun. 30, 2021

Accounting Changes And Error Corrections [Abstract]

New Accounting Standards

2. NEW ACCOUNTING STANDARDS

Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates ("ASUs") to the FASB’s Accounting Standards Codification ("ASC").

The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s consolidated financial statements.

Adoption of new accounting standards

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes. ASU 2019-12 is effective for public business entities for annual periods beginning after December 15, 2020, and early adoption is permitted. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The Company adopted ASU 2019-12 prospectively as of January 1, 2021, and the adoption did not have a material impact on the Company’s consolidated financial statements.

Accounting standards issued but not yet adopted

None that are expected to have an impact on the Company. 

XML

Fair Value Measurements

6 Months Ended

Jun. 30, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

3. FAIR VALUE MEASUREMENTS

Assets and liabilities measured at fair value on a recurring basis

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and other current financial assets and liabilities approximate their fair value because of the short-term maturity of these instruments.

The Company uses derivative financial instruments (“derivatives”) as part of its debt management to mitigate the market risk that occurs from its exposure to changes in interest rates and foreign exchange rates. The Company does not enter into derivatives for trading or other speculative purposes. The Company’s use of derivatives is in accordance with the strategies contained in the Company’s overall financial policy. All derivatives are recognized in the consolidated financial statements at fair value. For certain derivatives, hedge accounting is not applied either because non-hedge accounting treatment creates the same accounting result or the hedge does not meet the hedge accounting requirements, although each hedge is entered into applying the same rationale concerning mitigating market risk that occurs from changes in interest rates and foreign exchange rates.

The degree of judgment utilized in measuring the fair value of the instruments generally correlates to the level of pricing observability. Pricing observability is impacted by several factors, including the type of asset or liability, whether the asset or liability has an established market and the characteristics specific to the transaction. Instruments with readily active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of pricing observability and a lesser degree of judgment utilized in measuring fair value. Conversely, assets rarely traded or not quoted will generally have less, or no, pricing observability and a higher degree of judgment utilized in measuring fair value.

All the Company’s derivatives are classified as Level 2 financial instruments in the fair value hierarchy. Level 2 pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reported date. The nature of these assets and liabilities include items for which quoted prices are available but traded less frequently, and items that are fair valued using other financial instruments, the parameters of which can be directly observed.

The carrying value is the same as the fair value as these instruments are recognized in the consolidated financial statements at fair value. Although the Company is party to close-out netting agreements ("ISDA agreements") with all derivative counterparties, the fair values in the tables below and in the Condensed Consolidated Balance Sheets at June 30, 2021 and December 31, 2020 have been presented on a gross basis. According to the ISDA agreements, transaction amounts payable to a counterparty on the same date and in the same currency can be netted. The amounts subject to netting agreements that the Company chose not to offset are presented below.

Derivatives designated as hedging instruments

There were no derivatives designated as hedging instruments as of June 30, 2021 and December 31, 2020 related to the operations.

Derivatives not designated as hedging instruments

Derivatives not designated as hedging instruments relate to economic hedges and are marked to market with all amounts recognized in the Consolidated Statements of Income. The derivatives not designated as hedging instruments outstanding at June 30, 2021 and December 31, 2020 were foreign exchange swaps.

For the three month periods ended June 30, 2021 and June 30, 2020, the gains and losses recognized in other non-operating items, net were a gain of $20 million and a gain of $7 million, respectively, for derivative instruments not designated as hedging instruments. For the six month periods ended June 30, 2021 and June 30, 2020, the gains and losses recognized in other non-operating items, net were a loss of $38 million and a loss of $2 million, respectively, for derivative instruments not designated as hedging instruments. The realized part of the gains and losses referred to above are reported under financing activities in the statement of cash flows.

For the three and six month periods ended June 30, 2021 and June 30, 2020, the gains and losses recognized as interest expense were immaterial.

The tables below present information about the Company’s derivative financial assets and liabilities measured at fair value on a recurring basis (dollars in millions).

	June 30, 2021									December 31, 2020
				Fair Value Measurements									Fair Value Measurements
Description	Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)			Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)
Derivatives not designated as hedging    instruments
Foreign exchange swaps, less    than 6 months	$	1,300	1)	$	1	2)	$	16	3)	$	1,463	4)	$	25	5)	$	3	6)
Total derivatives not designated    as hedging instruments	$	1,300		$	1		$	16		$	1,463		$	25		$	3

1) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,300 million.

2) Net amount after deducting for offsetting swaps under ISDA agreements is $1 million.

3) Net amount after deducting for offsetting swaps under ISDA agreements is $16 million.

4) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,463 million.

5) Net amount after deducting for offsetting swaps under ISDA agreements is $25 million.

6) Net amount after deducting for offsetting swaps under ISDA agreements is $3 million.

Fair Value of Debt

The fair value of long-term debt is determined either from quoted market prices as provided by participants in the secondary market or for long-term debt without quoted market prices, estimated using a discounted cash flow method based on the Company’s current borrowing rates for similar types of financing. The Company has determined that each of these fair value measurements of debt reside within Level 2 of the fair value hierarchy.

The fair value and carrying value of debt is summarized in the table below (dollars in millions).

	June 30, 2021				December 31, 2020
	Carrying value1)		Fair value		Carrying value1)		Fair value
Long-term debt
Bonds	$	1,359	$	1,453	$	1,377	$	1,483
Loans		352		367		732		753
Other long-term debt		1		1		1		1
Total long-term debt		1,712		1,821		2,110		2,237
Short-term debt
Short-term portion of long-term debt		353		356		275		278
Overdrafts and other short-term debt		10		10		27		27
Total short-term debt	$	363	$	366	$	302	$	305

1) Debt as reported in balance sheet.

Assets and liabilities measured at fair value on a nonrecurring basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company also has assets and liabilities in its balance sheet that are measured at fair value on a nonrecurring basis, including certain long-lived assets, including equity method investments, goodwill and other intangible assets, typically as it relates to impairment.

The Company has determined that the fair value measurements included in each of these assets and liabilities rely primarily on Company-specific inputs and the Company’s assumptions about the use of the assets and settlements of liabilities, as observable inputs are not available. The Company has determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. To determine the fair value of long-lived assets, the Company utilizes the projected cash flows expected to be generated by the long-lived assets, then discounts the future cash flows over the expected life of the long-lived assets.

For the three and six month periods ended June 30, 2021 and June 30, 2020, the Company did not record any material impairment charges on its long-lived assets for its operations.

XML

Income Taxes

6 Months Ended

Jun. 30, 2021

Income Tax Disclosure [Abstract]

Income Taxes

4. INCOME TAXES

The effective tax rate for the three months period ended June 30, 2021 was 31.3% compared to 29.3% for the three months period ended June 30, 2020. Discrete tax items, net for the three months period ended June 30, 2021 had an unfavorable impact of 0.2%. Discrete tax items, net for the three months period ended June 30, 2020 had a favorable impact of 4.4%.

The effective tax rate for the six months period ended June 30, 2021 was 29.2% compared to 26.5% for the six months period ended June 30, 2020. Discrete tax items, net for the six months period ended June 30, 2021 had a favorable impact of 0.1%. Discrete tax items, net for the six months period ended June 30, 2020, had a favorable impact of 7.6%.

The Company files income tax returns in the U.S. federal jurisdiction, various U.S. states and non-U.S. jurisdictions. At any given time, the Company is undergoing tax audits in several tax jurisdictions covering multiple years. The Company is no longer subject to income tax examination by the U.S. federal income tax authorities for years prior to 2015. With few exceptions, the Company is no longer subject to income tax examination by U.S. state or local tax authorities or by non-U.S. tax authorities for years before 2010.

As of June 30, 2021, the Company is not aware of any proposed income tax adjustments resulting from tax examinations that would have a material impact on the Company’s condensed consolidated financial statements. The conclusion of such audits could result in additional increases or decreases to unrecognized tax benefits in some future period or periods.

During the six months period ended June 30, 2021, the Company recorded a net increase of $4 million to income tax reserves for unrecognized tax benefits based on tax positions related to the current year, including accruing additional interest related to unrecognized tax benefits from prior years. Of the total unrecognized tax benefits of $50 million recorded at June 30, 2021, $6 million is classified as current tax payable within Other current liabilities and $44 million is classified as non-current tax payable within Other non-current liabilities on the Condensed Consolidated Balance Sheet.

XML

Inventories

6 Months Ended

Jun. 30, 2021

Inventory Disclosure [Abstract]

Inventories

5. INVENTORIES

Inventories are stated at the lower of cost ("FIFO") and net realizable value. The components of inventories were as follows (dollars in millions):

	As of
	June 30, 2021			December 31, 2020
Raw materials	$	416		$	379
Work in progress		326			292
Finished products		249			220
Inventories		991			891
Inventory valuation reserve		(90	)		(93	)
Total inventories, net of reserve	$	901		$	798

XML

Restructuring

6 Months Ended

Jun. 30, 2021

Restructuring And Related Activities [Abstract]

Restructuring

6. RESTRUCTURING

As of June 30, 2021, approximately $52 million out of the $107 million in total reserve balance can be attributed to the structural efficiency program initiated in the second quarter of 2020. This program is expected to be concluded in 2021. Approximately $38 million of the total reserve balance can be attributed to footprint optimization activities in Europe initiated in the third quarter of 2020. These activities are expected to be concluded in 2023.

The table below summarizes the change in the balance sheet position of the employee related restructuring reserves (dollars in millions). The restructuring reserve balance is included within Accrued expenses in the Condensed Consolidated Balance Sheet. The changes in the employee-related reserves have been charged against Other income (expense), net in the Consolidated Statements of Income. Restructuring costs other than employee related costs are immaterial for all periods presented.

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Reserve at beginning of the period	$	113		$	52		$	126		$	56
Provision - charge		1			69			2			71
Provision - reversal		(0	)		(7	)		(0	)		(7	)
Cash payments		(8	)		(16	)		(17	)		(20	)
Translation difference		1			2			(4	)		0
Reserve at end of the period	$	107		$	100		$	107		$	100

XML

Product-Related Liabilities

6 Months Ended

Jun. 30, 2021

Product Warranties Disclosures [Abstract]

Product-Related Liabilities

7. PRODUCT-RELATED LIABILITIES

The Company is exposed to product liability and warranty claims in the event that the Company’s products fail to perform as represented and such failure results, or is alleged to result, in bodily injury, and/or property damage or other loss. The Company has reserves for product risks. Such reserves are related to product performance issues, including recalls, product liability and warranty issues. For further explanation, see Note 9. Contingent Liabilities below.

For the three and six month periods ended June 30, 2021, provisions primarily related to recall related issues. Cash payments in the three and six month periods ended June 30, 2021 mainly related to the “Toyota Recall” that was settled in April 2021. For the three and six month periods ended June 30, 2020, provisions and cash paid primarily related to recall and warranty related issues. As of June 30, 2021, the reserve for product related liabilities mainly related to recall related issues.

Pursuant to the agreements entered into in connection with the spin-off of Veoneer, Inc. on June 29, 2018 (collectively, the “Spin-off Agreements”), Autoliv is required to indemnify Veoneer for recalls related to certain qualified Electronics products. As of June 30, 2021, the indemnification liabilities are approximately $8 million and included within Accrued expenses on the Condensed Consolidated Balance Sheet.

The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions). A majority of the Company’s recall related issues as of June 30, 2021 are covered by insurance. Insurance receivables are included within Other current assets and Other non-current assets on the Condensed Consolidated Balance Sheet. As of June 30, 2021, the Company had total insurance receivables related to recall issues of $126 million. The total product liability reserve currently is less than the product liability insurance receivable because the timing of insurance recoveries does not match the timing of our product liability.

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Reserve at beginning of the period	$	328		$	54		$	341		$	72
Change in reserve		1			8			5			11
Cash payments		(237	)		(4	)		(243	)		(25	)
Translation difference		11			0			0			0
Reserve at end of the period	$	103		$	58		$	103		$	58

XML

Retirement Plans

6 Months Ended

Jun. 30, 2021

Compensation And Retirement Disclosure [Abstract]

Retirement Plans

8. RETIREMENT PLANS

The components of total Net Periodic Benefit Cost associated with the Company’s defined benefit retirement plans are as follows (dollars in millions):

U.S. Plans	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Service cost	$	2		$	2		$	4		$	4
Interest cost		2			3			5			7
Expected return on plan assets		(5	)		(4	)		(9	)		(8	)
Amortization of prior service (credit) cost		1			(1	)		0			(1	)
Amortization of actuarial loss		1			1			1			1
Net Periodic Benefit Cost	$	1		$	1		$	1		$	3
Non-U.S. Plans	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Service cost	$	3		$	3		$	6		$	6
Interest cost		2			1			3			3
Expected return on plan assets		(1	)		(0	)		(1	)		(1	)
Amortization of prior service (credit) cost		(0	)		0			0			0
Amortization of actuarial loss		1			0			1			1
Net Periodic Benefit Cost	$	5		$	4		$	9		$	9

The Service cost and Amortization of prior service cost components in the tables above are reported in Operating Income in the Consolidated Statements of Income. The remaining components - Interest cost, Expected return on plan assets, Amortization of actuarial loss and Settlement loss - are reported as Other non-operating items, net in the Consolidated Statements of Income.

XML

Contingent Liabilities

6 Months Ended

Jun. 30, 2021

Commitments And Contingencies Disclosure [Abstract]

Contingent Liabilities

9. CONTINGENT LIABILITIES

Legal Proceedings

Various claims, lawsuits and proceedings are pending or threatened against the Company or its subsidiaries, covering a range of matters that arise in the ordinary course of its business activities with respect to commercial, product liability and other matters. Litigation is subject to many uncertainties, and the outcome of any litigation cannot be assured. After discussions with counsel, it is the opinion of management that the various legal proceedings and investigations to which the Company currently is a party will not have a material adverse impact on the consolidated financial position of Autoliv, but the Company cannot provide assurance that Autoliv will not experience material litigation, product liability or other losses in the future.

ANTITRUST MATTERS

Authorities in several jurisdictions have conducted broad, and in some cases, long-running investigations of suspected anti-competitive behavior among parts suppliers in the global automotive vehicle industry. These investigations included, but are not limited to, the products that the Company sells. In addition to concluded matters, authorities of other countries with significant light vehicle manufacturing or sales may initiate similar investigations.

PRODUCT WARRANTY, RECALLS AND INTELLECTUAL PROPERTY

Autoliv is exposed to various claims for damages and compensation if its products fail to perform as expected. Such claims can be made, and result in costs and other losses to the Company, even where the product is eventually found to have functioned properly. Where a product (actually or allegedly) fails to perform as expected or is defective, the Company may face warranty and recall claims. Where such (actual or alleged) failure or defect results, or is alleged to result, in bodily injury and/or property damage or other loss, the Company may also face product liability and other claims. There can be no assurance that the Company will not experience material warranty, recall or product (or other) liability claims or losses in the future, or that the Company will not incur significant costs to defend against such claims. The Company may be required to participate in a recall involving its products. Each vehicle manufacturer has its own practices regarding product recalls and other product liability actions relating to its suppliers. As suppliers become more integrally involved in the vehicle design process and assume more of the vehicle assembly functions, vehicle manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and product liability claims. Government safety regulators may also play a role in warranty and recall practices. A warranty, recall or product-liability claim

brought against the Company in excess of its insurance may have a material adverse effect on the Company’s business. Vehicle manufacturers are also increasingly requiring their outside suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties. A vehicle manufacturer may attempt to hold the Company responsible for some, or all, of the repair or replacement costs of products when the product supplied did not perform as represented by us or expected by the customer. Accordingly, the future costs of warranty claims by customers may be material. However, the Company believes its established reserves are adequate. Autoliv’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.

In addition, as vehicle manufacturers increasingly use global platforms and procedures, quality performance evaluations are also conducted on a global basis. Any one or more quality, warranty or other recall issue(s) (including those affecting few units and/or having a small financial impact) may cause a vehicle manufacturer to implement measures such as a temporary or prolonged suspension of new orders, which may have a material impact on the Company’s results of operations.

The Company maintains a program of insurance, which may include commercial insurance, self-insurance, or a combination of both approaches, for potential recall and product liability claims in amounts and on terms that it believes are reasonable and prudent based on our prior claims experience. The Company’s insurance policies generally include coverage of the costs of a recall, although costs related to replacement parts are generally not covered. In addition, a number of the agreements entered into by the Company, including the Spin-off Agreements, require Autoliv to indemnify the other parties for certain claims. Autoliv cannot assure that the level of coverage will be sufficient to cover every possible claim that can arise in our businesses or with respect to other obligations, now or in the future, or that such coverage always will be available should we, now or in the future, wish to extend, increase or otherwise adjust our insurance.

Specific Recalls:

On June 29, 2016, the Company announced that it was cooperating with Toyota Motor Corp. in its recall of approximately 1.4 million vehicles equipped with a certain model of the Company’s side curtain airbag (the “Toyota Recall”). The Company determined pursuant to ASC 450 that a loss with respect to the Toyota Recall was probable and accrued an amount that was included in the total product liability accrual in the fourth quarter of 2020. The amount by which the product liability accrual exceeded the product liability insurance receivable with respect to the Toyota Recall was $25 million and included deductibles and replacement parts. The Company settled and resolved the Toyota Recall on April 27, 2021. The final amount by which the product liability accrual exceeded the product liability insurance receivable was $26 million, which is generally in line with our expectations disclosed in prior quarters. The matter is now closed.

Additionally, in the fourth quarter of 2020, the Company was made aware of a potential recall by one of its customers (the “Unannounced Recall”). The Company continues to evaluate this matter with its customer. The Company has determined pursuant to ASC 450 that a loss with respect to the Unannounced Recall is probable and has accrued an amount that is reflected in the total product liability accrual in the fourth quarter of 2020. The amount by which the product liability accrual exceeds the product liability insurance receivable with respect to the Unannounced Recall is $26 million and includes self-insurance retention costs and deductibles. The ultimate loss to the Company of the Unannounced Recall could be materially different from the amount the Company has accrued.

Intellectual Property:

In its products, the Company utilizes technologies which may be subject to intellectual property rights of third parties. While the Company does seek to procure the necessary rights to utilize intellectual property rights associated with its products, it may fail to do so. Where the Company so fails, the Company may be exposed to material claims from the owners of such rights. Where the Company has sold products which infringe upon such rights, its customers may be entitled to be indemnified by the Company for the claims they suffer as a result thereof. Such claims could be material.

The table in Note 7. Product-Related Liabilities above summarizes the change in the balance sheet position of the product-related liabilities.

XML

Stock Incentive Plan

6 Months Ended

Jun. 30, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Incentive Plan

10. STOCK INCENTIVE PLAN

Eligible employees and non-employee directors of the Company participate in the Autoliv, Inc.1997 Stock Incentive Plan, as amended and received Autoliv stock-based awards which include stock options ("SOs"), restricted stock units ("RSUs") and performance stock units ("PSUs").

For the three and six month periods ended June 30, 2021, the Company recorded approximately $4 million and $7 million, respectively, in stock-based compensation expense related to RSUs and PSUs. For the three and six month periods ended June 30, 2020, the Company recorded approximately $2 million and $4 million, respectively, in stock-based compensation expense related to RSUs and PSUs.

During the three and six month periods ended June 30, 2021, approximately 47 thousand and 116 thousand shares, respectively, of common stock from the treasury stock were utilized by the Plan. During the three and six month periods ended June 30, 2020, approximately 16 thousand and 86 thousand shares, respectively, of common stock from the treasury stock were utilized by the Plan.

XML

Earnings per share

6 Months Ended

Jun. 30, 2021

Earnings Per Share [Abstract]

Earnings per share

11. EARNINGS PER SHARE

The computation of basic and diluted EPS under the two-class method is set forth in the table below. Anti-dilutive shares outstanding were immaterial for all periods presented below. For the three and six month periods ended June 30, 2020, shares in the diluted loss per share calculation represent basic shares due to the net loss.

	Three months ended June 30					Six months ended June 30
(In millions, except per share amounts)	2021		2020			2021		2020
Numerator:
Basic and diluted:
Net income (loss) attributable to controlling interest	$	104	$	(175	)	$	261	$	(100	)
Participating share awards with dividend    equivalent rights		0		0			0		0
Net income (loss) applicable to common    shareholders		104		(175	)		261		(100	)
Earnings allocated to participating    share awards1)		0		0			0		0
Net income (loss) attributable to common    shareholders	$	104	$	(175	)	$	261	$	(100	)
Denominator: 1)
Basic: Weighted average common stock		87.4		87.3			87.4		87.3
Add: Weighted average stock options/    share awards		0.3		0.0			0.3		0.0
Diluted:		87.7		87.3			87.7		87.3
Net earnings (loss) per share - basic	$	1.19	$	(2.00	)	$	2.98	$	(1.14	)
Net earnings (loss) per share - diluted	$	1.19	$	(2.00	)	$	2.98	$	(1.14	)

1) The Company’s unvested RSUs and PSUs, of which some included the right to receive non-forfeitable dividend equivalents, are considered participating securities. Calculations of EPS under the two-class method exclude from the numerator any dividends paid or owed on participating securities and any undistributed earnings considered to be attributable to participating securities. The related participating securities are similarly excluded from the denominator.

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2021

Related Party Transactions [Abstract]

Related Party Transactions

12. RELATED PARTY TRANSACTIONS

The Company purchases finished goods from Veoneer. For the three and six month periods ended June 30, 2021, related party purchases from Veoneer amounted to $20 million and $41 million, respectively. For the three and six month periods ended June 30, 2020, related party purchases from Veoneer amounted to $11 million and $29 million, respectively.

Amounts due to and due from related party as of June 30, 2021 and December 31, 2020 were as follows:

	As of
(Dollars in millions)	June 30, 2021		December 31, 2020
Related party receivables1)	$	1	$	2
Related party payables2)		26		27
Related party accrued expenses3)		8		10

1) Included in Receivables, net in the Condensed Consolidated Balance Sheet.

2) Included in Accounts payable in the Condensed Consolidated Balance Sheet.

3) Included in Accrued expenses in the Condensed Consolidated Balance Sheet.

XML

Revenue Disaggregation

6 Months Ended

Jun. 30, 2021

Revenue From Contract With Customer [Abstract]

Revenue Disaggregation

13. REVENUE DISAGGREGATION

The Company’s disaggregated revenue for the three and six month periods ended June 30, 2021 and June 30, 2020 were as follows.

Net Sales by Products	Three months ended June 30				Six months ended June 30
(Dollars in millions)	2021		2020		2021		2020
Airbag Products and Other1)	$	1,310	$	654	$	2,773	$	1,856
Seatbelt Products1)		712		394		1,491		1,037
Total net sales	$	2,022	$	1,048	$	4,265	$	2,893
1) Including Corporate and other sales.
Net Sales by Region	Three months ended June 30				Six months ended June 30
(Dollars in millions)	2021		2020		2021		2020
Asia	$	794	$	588	$	1,671	$	1,185
Whereof: China		399		366		814		564
Japan		175		105		386		308
Rest of Asia		219		117		471		314
Americas		621		213		1,307		886
Europe		608		246		1,287		823
Total net sales	$	2,022	$	1,048	$	4,265	$	2,893

Contract Balances

Contract assets relate to the Company's rights to consideration for work completed but not billed (generally in conjunction with contracts for which revenue is recognized over time) at the reporting date on production parts and is included in Other current assets in the Condensed Consolidated Balance Sheet. The contract assets are reclassified into the receivables balance when the rights to receive payments become unconditional. The net change in the contract assets balance, reflecting the adjustments needed to align revenue recognition for work completed but not billed, for the three and six month periods ended June 30, 2021 and for the three and six month periods ended June 30, 2020 were not material in any period.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2021

Subsequent Events [Abstract]

Subsequent Events

14. SUBSEQUENT EVENTS

There were no reportable events subsequent to June 30, 2021.

XML

New Accounting Standards (Policies)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

New Accounting Standards

Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates ("ASUs") to the FASB’s Accounting Standards Codification ("ASC").

The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s consolidated financial statements.

Adoption of new accounting standards

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes. ASU 2019-12 is effective for public business entities for annual periods beginning after December 15, 2020, and early adoption is permitted. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The Company adopted ASU 2019-12 prospectively as of January 1, 2021, and the adoption did not have a material impact on the Company’s consolidated financial statements.

Accounting standards issued but not yet adopted

None that are expected to have an impact on the Company. 

Contingent Liabilities

Autoliv’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.

XML

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2021

Fair Value Disclosures [Abstract]

Derivative Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The tables below present information about the Company’s derivative financial assets and liabilities measured at fair value on a recurring basis (dollars in millions).

	June 30, 2021									December 31, 2020
				Fair Value Measurements									Fair Value Measurements
Description	Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)			Nominal volume			Derivative asset (Other current assets)			Derivative liability (Other current liabilities)
Derivatives not designated as hedging    instruments
Foreign exchange swaps, less    than 6 months	$	1,300	1)	$	1	2)	$	16	3)	$	1,463	4)	$	25	5)	$	3	6)
Total derivatives not designated    as hedging instruments	$	1,300		$	1		$	16		$	1,463		$	25		$	3

1) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,300 million.

2) Net amount after deducting for offsetting swaps under ISDA agreements is $1 million.

3) Net amount after deducting for offsetting swaps under ISDA agreements is $16 million.

4) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,463 million.

5) Net amount after deducting for offsetting swaps under ISDA agreements is $25 million.

6) Net amount after deducting for offsetting swaps under ISDA agreements is $3 million.

Fair Value of Debt

The fair value and carrying value of debt is summarized in the table below (dollars in millions).

	June 30, 2021				December 31, 2020
	Carrying value1)		Fair value		Carrying value1)		Fair value
Long-term debt
Bonds	$	1,359	$	1,453	$	1,377	$	1,483
Loans		352		367		732		753
Other long-term debt		1		1		1		1
Total long-term debt		1,712		1,821		2,110		2,237
Short-term debt
Short-term portion of long-term debt		353		356		275		278
Overdrafts and other short-term debt		10		10		27		27
Total short-term debt	$	363	$	366	$	302	$	305

1) Debt as reported in balance sheet.

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2021

Inventory Disclosure [Abstract]

Components of Inventories

Inventories are stated at the lower of cost ("FIFO") and net realizable value. The components of inventories were as follows (dollars in millions):

	As of
	June 30, 2021			December 31, 2020
Raw materials	$	416		$	379
Work in progress		326			292
Finished products		249			220
Inventories		991			891
Inventory valuation reserve		(90	)		(93	)
Total inventories, net of reserve	$	901		$	798

XML

Restructuring (Tables)

6 Months Ended

Jun. 30, 2021

Restructuring And Related Activities [Abstract]

Schedule of Change in Balance Sheet Position of Employee Related Restructuring Reserves

The table below summarizes the change in the balance sheet position of the employee related restructuring reserves (dollars in millions). The restructuring reserve balance is included within Accrued expenses in the Condensed Consolidated Balance Sheet. The changes in the employee-related reserves have been charged against Other income (expense), net in the Consolidated Statements of Income. Restructuring costs other than employee related costs are immaterial for all periods presented.

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Reserve at beginning of the period	$	113		$	52		$	126		$	56
Provision - charge		1			69			2			71
Provision - reversal		(0	)		(7	)		(0	)		(7	)
Cash payments		(8	)		(16	)		(17	)		(20	)
Translation difference		1			2			(4	)		0
Reserve at end of the period	$	107		$	100		$	107		$	100

XML

Product-Related Liabilities (Tables)

6 Months Ended

Jun. 30, 2021

Product Warranties Disclosures [Abstract]

Schedule of Change in Balance Sheet Position of Product-Related Liabilities

The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions).

	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Reserve at beginning of the period	$	328		$	54		$	341		$	72
Change in reserve		1			8			5			11
Cash payments		(237	)		(4	)		(243	)		(25	)
Translation difference		11			0			0			0
Reserve at end of the period	$	103		$	58		$	103		$	58

XML

Retirement Plans (Tables)

6 Months Ended

Jun. 30, 2021

Pension Plans, Defined Benefit

Schedule of Components of Net Periodic Benefit Cost

The components of total Net Periodic Benefit Cost associated with the Company’s defined benefit retirement plans are as follows (dollars in millions):

U.S. Plans	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Service cost	$	2		$	2		$	4		$	4
Interest cost		2			3			5			7
Expected return on plan assets		(5	)		(4	)		(9	)		(8	)
Amortization of prior service (credit) cost		1			(1	)		0			(1	)
Amortization of actuarial loss		1			1			1			1
Net Periodic Benefit Cost	$	1		$	1		$	1		$	3
Non-U.S. Plans	Three months ended June 30						Six months ended June 30
	2021			2020			2021			2020
Service cost	$	3		$	3		$	6		$	6
Interest cost		2			1			3			3
Expected return on plan assets		(1	)		(0	)		(1	)		(1	)
Amortization of prior service (credit) cost		(0	)		0			0			0
Amortization of actuarial loss		1			0			1			1
Net Periodic Benefit Cost	$	5		$	4		$	9		$	9

XML

Earnings per share (Tables)

6 Months Ended

Jun. 30, 2021

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted EPS under Two-class Method

The computation of basic and diluted EPS under the two-class method is set forth in the table below. Anti-dilutive shares outstanding were immaterial for all periods presented below. For the three and six month periods ended June 30, 2020, shares in the diluted loss per share calculation represent basic shares due to the net loss.

	Three months ended June 30					Six months ended June 30
(In millions, except per share amounts)	2021		2020			2021		2020
Numerator:
Basic and diluted:
Net income (loss) attributable to controlling interest	$	104	$	(175	)	$	261	$	(100	)
Participating share awards with dividend    equivalent rights		0		0			0		0
Net income (loss) applicable to common    shareholders		104		(175	)		261		(100	)
Earnings allocated to participating    share awards1)		0		0			0		0
Net income (loss) attributable to common    shareholders	$	104	$	(175	)	$	261	$	(100	)
Denominator: 1)
Basic: Weighted average common stock		87.4		87.3			87.4		87.3
Add: Weighted average stock options/    share awards		0.3		0.0			0.3		0.0
Diluted:		87.7		87.3			87.7		87.3
Net earnings (loss) per share - basic	$	1.19	$	(2.00	)	$	2.98	$	(1.14	)
Net earnings (loss) per share - diluted	$	1.19	$	(2.00	)	$	2.98	$	(1.14	)

1) The Company’s unvested RSUs and PSUs, of which some included the right to receive non-forfeitable dividend equivalents, are considered participating securities. Calculations of EPS under the two-class method exclude from the numerator any dividends paid or owed on participating securities and any undistributed earnings considered to be attributable to participating securities. The related participating securities are similarly excluded from the denominator.

XML

Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2021

Related Party Transactions [Abstract]

Summary of Amounts Due to and Due from Related Party

Amounts due to and due from related party as of June 30, 2021 and December 31, 2020 were as follows:

	As of
(Dollars in millions)	June 30, 2021		December 31, 2020
Related party receivables1)	$	1	$	2
Related party payables2)		26		27
Related party accrued expenses3)		8		10

1) Included in Receivables, net in the Condensed Consolidated Balance Sheet.

2) Included in Accounts payable in the Condensed Consolidated Balance Sheet.

3) Included in Accrued expenses in the Condensed Consolidated Balance Sheet.

XML

Revenue Disaggregation (Tables)

6 Months Ended

Jun. 30, 2021

Revenue From Contract With Customer [Abstract]

Schedule of Disaggregated Revenue by Products and Region

The Company’s disaggregated revenue for the three and six month periods ended June 30, 2021 and June 30, 2020 were as follows.

Net Sales by Products	Three months ended June 30				Six months ended June 30
(Dollars in millions)	2021		2020		2021		2020
Airbag Products and Other1)	$	1,310	$	654	$	2,773	$	1,856
Seatbelt Products1)		712		394		1,491		1,037
Total net sales	$	2,022	$	1,048	$	4,265	$	2,893
1) Including Corporate and other sales.
Net Sales by Region	Three months ended June 30				Six months ended June 30
(Dollars in millions)	2021		2020		2021		2020
Asia	$	794	$	588	$	1,671	$	1,185
Whereof: China		399		366		814		564
Japan		175		105		386		308
Rest of Asia		219		117		471		314
Americas		621		213		1,307		886
Europe		608		246		1,287		823
Total net sales	$	2,022	$	1,048	$	4,265	$	2,893

XML

Basis of Presentation - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2021 Segment
Accounting Policies [Abstract]
Number of reportable segments	1

XML

Fair Value Measurements - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Fair Value, Measurements, Nonrecurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset impairment charges			$ 0	$ 0
Not Designated as Hedging Instrument
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives designated as hedging instruments	$ 0		0		$ 0
Gains and losses recognized in other non-operating items, net	$ 20,000,000	$ 7,000,000	$ (38,000,000)	$ (2,000,000)

XML

Derivative Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Not Designated as Hedging Instrument - Fair Value, Measurements, Recurring - USD ($)	Jun. 30, 2021		Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Nominal volume	$ 1,300,000,000		$ 1,463,000,000
Other current assets
Derivatives, Fair Value [Line Items]
Derivative asset (Other current assets)	1,000,000		25,000,000
Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability (Other current liabilities)	16,000,000		3,000,000
Less Than Six Months | Foreign Exchange Swaps
Derivatives, Fair Value [Line Items]
Nominal volume	1,300,000,000	[1]	1,463,000,000	[2]
Less Than Six Months | Other current assets | Foreign Exchange Swaps
Derivatives, Fair Value [Line Items]
Derivative asset (Other current assets)	1,000,000	[3]	25,000,000	[4]
Less Than Six Months | Other current liabilities | Foreign Exchange Swaps
Derivatives, Fair Value [Line Items]
Derivative liability (Other current liabilities)	$ 16,000,000	[5]	$ 3,000,000	[6]

[1] Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,300 million.

[2] Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,463 million.

[3] Net amount after deducting for offsetting swaps under ISDA agreements is $1 million.

[4] Net amount after deducting for offsetting swaps under ISDA agreements is $25 million.

[5] Net amount after deducting for offsetting swaps under ISDA agreements is $16 million.

[6] Net amount after deducting for offsetting swaps under ISDA agreements is $3 million.

XML

Derivative Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Parenthetical) (Detail) - Not Designated as Hedging Instrument - Foreign Exchange Swaps - Fair Value, Measurements, Recurring - Less Than Six Months - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Derivative notional volume, amount after offsetting swaps	$ 1,300	$ 1,463
Other current assets
Derivatives, Fair Value [Line Items]
Derivative asset, amount after offsetting swaps	1	25
Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, amount after offsetting swaps	$ 16	$ 3

XML

Fair Value of Debt (Detail) - USD ($) $ in Millions		Jun. 30, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt	[1]	$ 1,712	$ 2,110
Short-term debt	[1]	363	302
Long-term debt, fair value		1,821	2,237
Short-term debt, fair value		366	305
Bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt	[1]	1,359	1,377
Long-term debt, fair value		1,453	1,483
Other Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt	[1]	1	1
Long-term debt, fair value		1	1
Loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt	[1]	352	732
Long-term debt, fair value		367	753
Overdrafts and Other Short-Term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term debt	[1]	10	27
Short-term debt, fair value		10	27
Short-Term Portion of Long-Term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term debt	[1]	353	275
Short-term debt, fair value		$ 356	$ 278

[1] Debt as reported in balance sheet.

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Taxes [Line Items]
Effective income tax rate	31.30%	29.30%	29.20%	26.50%
Increase/(decrease) in effective tax rate due to impact of discrete tax items	0.20%	4.40%	0.10%	7.60%
Net increase to income tax reserves for unrecognized tax benefits based on tax positions related to current and prior years			$ 4
Unrecognized tax benefits reserve that would impact effective tax rate if released into income	$ 50		50
Current Tax Payable Within Other Current Liabilities
Income Taxes [Line Items]
Unrecognized tax benefits reserve that would impact effective tax rate if released into income	6		6
Non-Current Tax Payable Within Other Non-current Liabilities
Income Taxes [Line Items]
Unrecognized tax benefits reserve that would impact effective tax rate if released into income	$ 44		$ 44

XML

Components of Inventories (Detail) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 416	$ 379
Work in progress	326	292
Finished products	249	220
Inventories	991	891
Inventory valuation reserve	(90)	(93)
Total inventories, net of reserve	$ 901	$ 798

XML

Restructuring - Additional Information (Detail) $ in Millions	Jun. 30, 2021 USD ($)
Restructuring Cost and Reserve [Line Items]
Total restructuring reserve balance	$ 107
Structural Efficiency Restructuring Program
Restructuring Cost and Reserve [Line Items]
Total restructuring reserve balance	52
Footprint Optimization Activities | Europe
Restructuring Cost and Reserve [Line Items]
Total restructuring reserve balance	$ 38

XML

Schedule of Changes in Balance Sheet Position of Employee Related Restructuring Reserves (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Restructuring Cost and Reserve [Line Items]
Reserve at end of the period	$ 107		$ 107
Restructuring employee-related
Restructuring Cost and Reserve [Line Items]
Reserve at beginning of the period	113	$ 52	126	$ 56
Provision - charge	1	69	2	71
Provision - reversal	0	(7)	0	(7)
Cash payments	(8)	(16)	(17)	(20)
Translation difference	1	2	(4)	0
Reserve at end of the period	$ 107	$ 100	$ 107	$ 100

XML

Product-Related Liabilities - Additional Information (Detail) $ in Millions	Jun. 30, 2021 USD ($)
Product Warranty Liability [Line Items]
Insurance receivables related to recall issues	$ 126
Accrued Expenses
Product Warranty Liability [Line Items]
Indemnification liabilities	$ 8

XML

Summary of Change in Balance Sheet Position of Product-Related Liabilities (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Product Warranties Disclosures [Abstract]
Reserve at beginning of the period	$ 328.0	$ 54.0	$ 341.0	$ 72.0
Change in reserve	1.0	8.0	5.0	11.0
Cash payments	(237.0)	(4.0)	(243.0)	(25.0)
Translation difference	11.0	0.0	0.0	0.0
Reserve at end of the period	$ 103.0	$ 58.0	$ 103.0	$ 58.0

XML

Components of Net Periodic Benefit Cost (Detail) - Pension Plans, Defined Benefit - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
U.S. Pension Plans
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	$ 2	$ 2	$ 4	$ 4
Interest cost	2	3	5	7
Expected return on plan assets	(5)	(4)	(9)	(8)
Amortization of prior service (credit) cost	1	(1)	0	(1)
Amortization of actuarial loss	1	1	1	1
Net Periodic Benefit Cost	1	1	1	3
Non-U.S. Pension Plans
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	3	3	6	6
Interest cost	2	1	3	3
Expected return on plan assets	(1)	0	(1)	(1)
Amortization of prior service (credit) cost	0	0	0	0
Amortization of actuarial loss	1	0	1	1
Net Periodic Benefit Cost	$ 5	$ 4	$ 9	$ 9

XML

Contingent Liabilities - Additional Information (Detail) Vehicle in Millions, $ in Millions	Jun. 29, 2016 Vehicle	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Loss Contingencies [Line Items]
Product liability accrual		$ 103	$ 328	$ 341	$ 58	$ 54	$ 72
Damages from Product Defects
Loss Contingencies [Line Items]
Number of vehicles recalled | Vehicle	1.4
Toyota Recall | Damages from Product Defects
Loss Contingencies [Line Items]
Product liability accrual				25
Product liability insurance receivable		$ 26
Unannounced Recall | Damages from Product Defects
Loss Contingencies [Line Items]
Product liability accrual				$ 26

XML

Stock Incentive Plan - Additional Information (Detail) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share Based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares from treasury stock utilized by the Plan	47	16	116	86
Restricted Stock Units And Performance Stock Units
Share Based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation cost	$ 4	$ 2	$ 7	$ 4

XML

Schedule of Computation of Basic and Diluted EPS under Two-class Method (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Basic and diluted:
Net income (loss) attributable to controlling interest		$ 104	$ (175)	$ 261	$ (100)
Participating share awards with dividend equivalent rights		0	0	0	0
Net income (loss) applicable to common shareholders		104	(175)	261	(100)
Earnings allocated to participating share awards	[1]	0	0	0	0
Net income (loss) attributable to common shareholders		$ 104	$ (175)	$ 261	$ (100)
Denominator:
Basic: Weighted average common stock	[1]	87.4	87.3	87.4	87.3
Add: Weighted average stock options/share awards	[1]	0.3	0.0	0.3	0.0
Diluted:		87.7	87.3	87.7	87.3
Net earnings (loss) per share - basic	[2]	$ 1.19	$ (2.00)	$ 2.98	$ (1.14)
Net earnings (loss) per share - diluted	[2]	$ 1.19	$ (2.00)	$ 2.98	$ (1.14)

[1] The Company’s unvested RSUs and PSUs, of which some included the right to receive non-forfeitable dividend equivalents, are considered participating securities. Calculations of EPS under the two-class method exclude from the numerator any dividends paid or owed on participating securities and any undistributed earnings considered to be attributable to participating securities. The related participating securities are similarly excluded from the denominator.

[2] Participating share awards with the right to receive dividend equivalents are (under the two-class method) excluded from the earnings per share calculation (see Note 11 to the unaudited condensed consolidated financial statements).

XML

Related Party Transactions - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Veoneer, Inc.
Related Party Transaction [Line Items]
Purchases from related party	$ 20	$ 11	$ 41	$ 29

XML

Summary of Amounts Due to and Due from Related Party (Detail) - USD ($) $ in Millions		Jun. 30, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Related party receivables	[1]	$ 1	$ 2
Related party payables	[2]	26	27
Related party accrued expenses	[3]	$ 8	$ 10

[1] Included in Receivables, net in the Condensed Consolidated Balance Sheet.

[2] Included in Accounts payable in the Condensed Consolidated Balance Sheet.

[3] Included in Accrued expenses in the Condensed Consolidated Balance Sheet.

XML

Schedule of Disaggregated Revenue by Products and Region (Detail) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation Of Revenue [Line Items]
Net sales		$ 2,022	$ 1,048	$ 4,265	$ 2,893
Airbag Products and Other
Disaggregation Of Revenue [Line Items]
Net sales	[1]	1,310	654	2,773	1,856
Seatbelt Products
Disaggregation Of Revenue [Line Items]
Net sales	[1]	712	394	1,491	1,037
Asia
Disaggregation Of Revenue [Line Items]
Net sales		794	588	1,671	1,185
China
Disaggregation Of Revenue [Line Items]
Net sales		399	366	814	564
Japan
Disaggregation Of Revenue [Line Items]
Net sales		175	105	386	308
Rest of Asia
Disaggregation Of Revenue [Line Items]
Net sales		219	117	471	314
Americas
Disaggregation Of Revenue [Line Items]
Net sales		621	213	1,307	886
Europe
Disaggregation Of Revenue [Line Items]
Net sales		$ 608	$ 246	$ 1,287	$ 823

[1] Including Corporate and other sales.